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He that would enjoy life and act with freedom must have the work of the day 
continually before his eyes. Not yesterday's work, lest he fall into despair; nor 
to-morrow's, lest he become a visionary—not that which ends with the day, 
which is a worldly work; nor yet that only which remains to eternity, for by it 
he cannot shape his actions. 
Happy is the man who can recognize in the work of to-day a connected portion 
of the work of life and an embodiment of the work of Eternity. The foundations 
of his confidence are unchangeable, for he has been made a partaker of 
Infinity. He strenuously works out his daily enterprises because the present is 
given him for a possession. 
Thus ought Man to be an impersonation of the divine process of nature, and to 
show forth the union of the infinite with the finite, not slighting his temporal 
existence, remembering that in it only is individual action possible; nor yet 
shutting out from his view that which is eternal, knowing that Time is a 
mystery which man cannot endure to contemplate until eternal Truth 
enlighten it.  
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Radiofrequency (RF) ablation has become an important ablative technique 
widely used in the area of minimally invasive therapies of the modern 
medicine. The advancement in the field of RF-based technologies over the 
years has led to a growing number of applications in different therapeutic 
areas such as cardiac arrhythmias, epilepsy, oncology, assisted resection, 
apnea, pain or aesthetic surgery. There is, however, a constant need for the 
development of computer and experimental studies, which would enhance the 
performance and safety of these techniques. 
The main focus of this PhD Thesis was on examining the thermal and 
electrical phenomena behind tissue radiofrequency ablation in order to 
improve the efficacy and safety of the RF-based therapies and applicators. 
Two main areas of interest were pain management and oncology, which were 
organized into three independent studies. The research methodology was 
based on computer modeling and experimental studies on phantoms, ex vivo 
and in vivo models, and clinical trials.  
The research on pain management involved the analysis of electrical and 
thermal effects of the pulsed radiofrequency (PRF) treatment and the related 
risk of tissue thermal damage. Different pulse protocols used in clinical 
practice were studied using computer modeling and the study accuracy was 
validated by means of agar phantom model. Additional computer models for 
alternative pulse protocols were also proposed, in which thermal effect would 
be reduced but the electrical effect would remain unchanged. The study also 
discussed the concept of a mild electroporation from PRF.  
In the area of oncology, two different techniques were analyzed. First study 
focused on examining tissue hydration technique during RF ablation with a 
novel internally cooled wet (ICW) electrode. The new design involved two 




improve the accuracy of computer model of tumor RF ablation using a 
realistic geometry of saline distribution in tissue, and to assess the 
performance of the RF catheter. Different cases of saline-infused tumor were 
modeled and the simulated results were compared with the clinical data from 
a trial on 17 hepatic cancer patients. An in vivo study on pig liver model was 
used to obtain a realistic spatial distribution of the infused saline.  
The second study focused on the development of a new catheter-based 
endoluminal sealing technique as more effective alternative for management 
of the pancreatic stump. The method consisted of the impedance-guided 
radiofrequency ablation with pullback. Fine-tuning involving RF catheter 
type and ablation protocol was performed using ex vivo porcine models, and 







La ablación por radiofrecuencia (RF) se ha convertido en una técnica 
ablativa importante, ampliamente utilizada en el área de las terapias 
mínimamente invasivas de la medicina moderna. El avance en el campo de 
las tecnologías basadas en RF a lo largo de los años ha llevado a un número 
creciente de aplicaciones en diferentes áreas terapéuticas tales como 
arritmias cardíacas, epilepsia, oncología, resección asistida, apnea, dolor o 
cirugía estética. Sin embargo, existe una constante necesidad de desarrollar 
estudios computacionales y experimentales para mejorar el rendimiento de 
estas técnicas. 
El enfoque principal de esta tesis doctoral está centrado en examinar los 
efectos térmicos y eléctricos de ablación por radiofrecuencia de tejidos para 
mejorar la eficacia y la seguridad de las terapias y dispositivos basados en 
energía de radiofrecuencia. Las dos áreas principales de interés han sido el 
tratamiento del dolor y la cirugía hepática oncológica, que se han organizado 
en tres estudios independientes. La metodología de los estudios se ha basado 
en modelos computacionales y estudios experimentales sobre phantom de 
agar, modelos ex vivo e in vivo y ensayos clínicos. 
El estudio focalizado en el tratamiento del dolor ha incluido el análisis de 
los efectos eléctricos y térmicos del tratamiento con radiofrecuencia pulsada 
(PRF) y el riesgo relacionado con el daño térmico al tejido. Se han estudiado 
diferentes protocolos pulsados empleados en la práctica clínica utilizando 
modelos computacionales. La exactitud del modelo se ha validado mediante 
un modelo en phantom de agar. Se han propuesto también modelos 
computacionales adicionales para los protocolos pulsados alternativos en los 
cuales se reduciría el efecto térmico sin afectar al efecto eléctrico. En el 
estudio se ha discutido también el concepto de electroporación leve como el 




En el área de la cirugía hepática oncológica se han analizado dos técnicas 
diferentes. El primer estudio se ha centrado en examinar la hidratación del 
tejido durante la ablación por RF con un nuevo electrodo ICW. El nuevo 
diseño ha incluido dos agujas de perfusión expandibles integradas en el 
catéter. El objetivo principal ha sido mejorar la precisión del modelo 
computacional de ablación por RF de tumor utilizando una geometría realista 
de la distribución de solución salina en el tejido y evaluar el rendimiento del 
catéter de RF. Se han modelado diferentes casos de tumor infundido con 
solución salina y los resultados simulados se han comparado con los datos 
clínicos de un ensayo en 17 pacientes con cáncer hepático. Con el fin de 
obtener una distribución espacial realista de la solución salina infundida, se 
ha empleado un estudio in vivo sobre el modelo de hígado de cerdo. 
El segundo estudio se ha centrado en el desarrollo de una nueva técnica de 
sellado endoluminal basada en catéter, como una alternativa más efectiva 
para el manejo del remanente pancreático. El método ha consistido en una 
ablación por radiofrecuencia guiada por impedancia con la técnica de 
pullback. El ajuste del tipo de catéter de RF y del protocolo de ablación se ha 
realizado mediante modelos porcinos ex vivo. Posteriormente, la efectividad 






L'ablació per radiofreqüència (RF) s'ha convertit en una tècnica ablativa 
important, àmpliament utilitzada en l'àrea de les teràpies mínimament 
invasives de la medicina moderna. L'avanç en el camp de les tecnologies 
basades en RF al llarg dels anys ha portat a un número creixent d'aplicacions 
en diferents àrees terapèutiques com ara arítmies cardíaques, epilèpsia, 
oncologia, resecció assistida, apnea, dolor o cirurgia estètica. No obstant això, 
hi ha una constant necessitat de desenvolupar estudis computacionals i 
experimentals per a millorar el rendiment d'aquestes tècniques. 
Aquesta tesi doctoral ha estat centrada en examinar els efectes tèrmics i 
elèctrics de l'ablació per radiofreqüència de teixits per tal de millorar l'eficàcia 
i la seguretat de les teràpies i dispositius basats en energia de 
radiofreqüència. Dos àrees principals són el tractament del dolor i la cirurgia 
hepàtica. Aquestos han sigut organitzats en tres estudis independents. La 
metodologia dels estudis ha estat basada en models computacionals i 
experimentals sobre phantom d'agar, models ex vivo i in vivo i assajos clínics. 
L'estudi enfocat en el tractament del dolor ha inclòs l'anàlisi dels efectes 
elèctrics i tèrmics del tractament amb radiofreqüència polsada (PRF) i el risc 
relacionat amb el dany tèrmic al teixit. S'han estudiat diferents protocols 
polsats emprats en la pràctica clínica utilitzant models computacionals. 
L'exactitud del model ha estat validada per mitjà d'un model de phantom 
d'agar. S'han proposat també models computacionals addicionals per a 
protocols polsats alternatius en els quals es reduiria l'efecte tèrmic sense 
afectar  l’efecte elèctric. En aquest estudi s'ha discutit també el concepte 
d'electroporació lleu com el resultat de PRF. 
A l’àrea de la cirugía hepàtica han sigut analitzades dos tècniques 
diferents. El primer estudi s‘ha centrat en la hidratació del teixit durant 




agulles de perfusió expandibles integrades en el catèter. L’ objetiu principal 
ha sigut millorar la precisió del model computacional d’ ablació de tumors per 
RF utilitzant una geometria realista per a la distribució de sèrum salií en el 
teixit i evaluar el rendiment del catèter de RF. S’han modelat diferents casos 
de tumor infundit amb sèrum salí i els resultats simulats han sigut comparats 
amb les dades clíniques d‘un assaig dut a terme sobre 17 pacients amb càncer 
hepàtic. Amb l’objetiu d’obtenir una distribució espacial realista del sèrum 
salí injectat, s’ha du a terme un estudi in vivo basat en un model de fetge de 
porc. 
El segon estudi s'ha centrat en el desenvolupament d'una nova tècnica de 
tancament endoluminal bassat en catèter, com una alternativa més efectiva 
per a gestionar el romanent pancreàtic. El mètode ha consistit en una ablació 
per radiofreqüència guiada per impedància amb la tècnica de pullback. 
L'ajust del tipus de catèter de RF i del protocol d'ablació ha sigut realitzat per 
mitjà de models porcins ex vivo. Posteriorment, l'efectivitat del tancament ha 






This work is a part of my journey through the world of Biomedical 
Engineering that started ten years ago in my home country and brought me 
to Spain in pursuit of new experiences, international expertise and carrier 
development. This new chapter in my life not only allowed me to acquire the 
desired knowledge, but also surprised me with great challenges, unexpected 
opportunities, dear friendships and inspirational role models to follow. It has 
also given me a chance to assist international conferences and collaborate 
with various international research institutes, which resulted in an enriching 
and extraordinary learning and networking experience. 
Regarding biomedical research area, it has always been my desire to 
work in the field of engineering applied in medicine with a particular focus 
on the research and development of biomedical devices. This has motivated 
my master studies with specialization in Bioelectronics and Biomedical 
Instrumentation and given the opportunity to carry on with PhD degree. My 
PhD research has been influenced by different collaboration opportunities, 
from which have emerged topics that I have studied throughout the progress 
of the doctoral program. As a result, they might be mistakenly perceived as 
unrelated works. Nonetheless, the main motivation behind this dissertation 
was to contribute to research on radiofrequency ablation (RFA) applied in 
minimally invasive procedures in order to deepen the understanding of its 
mechanisms and capacities and improve the performance as therapeutic 
technique. The general objectives of this work can be defined as: (1) 
development of computer models to study electrical and thermal effects of 
RFA for tissue selective destruction applied in tumor focal ablation and 
surgical resection; and (2) ex vivo and in vivo experimental validation of 




Three different studies were developed within the scope of the general 
objectives that contributed to accomplishment of the main aim of the present 
dissertation. These involved the study on: (1) the electrical and thermal 
effects of different pulsed radiofrequency protocols on computer and phantom 
models; (2) the internally cooled wet radiofrequency electrode performance 
and tissue hydration on hepatic tissue ex vivo and computer models; and (3) 
the development of catheter-based endoluminal radiofrequency sealing 
technique. 
 
Structure of the document 
This document is arranged into six main chapters. Chapter 1 is an 
introduction that integrates the overview of the ablative techniques used in 
minimally invasive therapies, general principles and applications of RFA, 
along with its research methodology. Chapters 2, 3 and 4 contain the three 
research studies conducted, and which has already been published as 
separate original articles in The International Journal of Hyperthermia, 
which is the official journal of the Society for Thermal Medicine (N. America), 
the European Society for Hyperthermic Oncology, and the Japanese Society 
for Thermal Medicine. 
General discussion on the overall results of this work and final 
conclusions are included in Chapter 5 and 6, respectively. Lastly, the last two 
sections mention all the publications and participation in scientific meetings 
and conference throughout the duration of my PhD program. 
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Figure 18. Transversal diameters of the coagulation zones computed for the 
considered cases A–F. Horizontal lines are the mean transversal diameter 
found in the clinical trials (dashed line) and the “corrected value” by 
taking the shrinkage effect into account (dotted line). The colored band 
thus represents the range in which the clinical and computed results 
would match. ----------------------------------------------------------------------------- 100 
Figure 19. (a) Overview of the catheter-based technique for endoluminal 
radiofrequency sealing of pancreatic duct. The catheter is introduced into 
the pancreatic duct through the papilla. (b) Detail of catheter tip in which 
RF power is applied between two electrodes. The thermal lesion causes 
the duct to seal (the illustration is that of a human pancreas). (c) 5 Fr 
bipolar RF catheter used for ex vivo ablations on bovine liver (the most 
proximal electrodes were used for ablations). (d) 3 Fr bipolar RF catheter 
used for ex vivo and in vivo ablations on porcine pancreas. -------------- 115 
Figure 20. Results of the second set of ex vivo experiments. (a)-(c) Examples 
of impedance evolution. (a) Small-amplitude sawtooth associated with 
slow and intermittent catheter pullback. (b) and (c) Smooth patterns 
associated with slow and continuous catheter pullback. (d) Thermal lesion 
created on bovine liver by slow and continuous pullback (impedance 
shown in (b). ----------------------------------------------------------------------------- 120 
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Figure 21. Results of the third set of ex vivo experiments. (a) Typical 
impedance during ablation. (b) Lesion created along the pancreatic duct 
in a pancreas treated with 43 V and pullback as continuous as possible. 
Gray bands show power cut off instants after abrupt impedance increases 
associated with tissue sticking and carbonization (black arrow in (b)). 
After this event pullback was always speeded up in order to relocate the 
catheter, which in turn led to some visible gaps (white arrow in (b)). 122 
Figure 22. Results of the in vivo experiments. Macroscopic images of one of 
the treated pancreas and cross sections at the level of the head (a) and 
body (b). Red dotted circles indicate the position of the main duct. Lumen 
was not completely closed in all cases and ductal dilation was observed, 
particularly in the body (units in cm). Grey dashed line indicates the main 
duct position in pancreas.------------------------------------------------------------ 123 
Figure 23. Results of in vivo experiment. Histological images of normal 
pancreas (a)-(c) and samples with sealing-induced pancreatic atrophy (d)-
(f). Compared to normal pancreatic tissue, the treated samples show 
evident atrophy of the acinar component (purple dye) with only 
intralobular ducts remaining (d,e); the epithelium of the interlobular 
ducts is flattened or has been lost ((f), black arrow); marked interlobular 
fibrosis (d)-(f); scattered inflammatory infiltrate (e,f). H&E ×5 (a,d) and 
×20 (b,c,e,f). ------------------------------------------------------------------------------ 124 
  






This chapter presents an overview of techniques, concepts and principles that 
are involved in the field of radiofrequency-based minimally invasive 
therapies, and which were used for the accomplishment of this work. Thus, 
the following paragraphs include a general outline of the different energy 
sources and applications in the context of high-temperature ablative 
techniques along with specific applications and therapies that employ 
techniques based on radiofrequency (RF) ablation (RFA). Next, a description 
of RFA physical principles and RF applicators is included. The last section of 
this chapter describes different methodologies of research utilized in this 
work, such as computer and experimental modeling, and highlights the key 
objectives and contributions to the current state of knowledge.   
 
1.1.  High-temperature ablative techniques 
Over the past few decades medicine has been transformed by a rapid growth 
of technological advancement. This included also the area of surgical 
techniques, which was boosted by the modern era pursuit of quality 
improvement in healthcare. The development of imaging techniques for 
interventional procedures was fundamental for evolution of image-guided 
minimally invasive surgery, in particular thermal ablation that has become 
a vital field of operative medicine.  
The term thermal ablation refers to abnormal tissue destruction or 
removal using elevated or depressed tissue temperatures, which is achieved 
by using different energy sources such as high intensity focused ultrasound 
(HIFU), radiofrequency (RF), microwaves, laser energy or cryoablation. These 
techniques have been evolved and employed in the treatment of local 
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malignancies as alternatives to open surgery. As minimally invasive 
strategies, they aim primarily at enhancing patient outcome and system 
performance in terms of time and cost-effectiveness. They also offer the 
advantage of treating patients who are not candidates for conventional 
therapy. These facts have led to the development of effective therapies with 
demonstrated reduction of pain and surgical trauma and faster patient 
recovery compared to traditional, open surgery. Subsequently, the reported 
clinical trials involve hepatic and brain cancer, renal, breast and lung tumors 
and bony lesions treatments [1-16]. However, there is no clear evidence of the 
superior effectiveness of these techniques over traditional surgery due to the 
existing tumor recurrence rate, and often they are proposed in combination 
with other therapies such as e.g. chemotherapy or radiotherapy [17,18]. This 
condition, however, challenges research to make progress towards developing 
new designs in RF techniques and devices that would improve their 
performance.   
The convenience of choosing one or another ablation technique depends 
on the specificity of the case and patient. In general, thermal ablation 
typically involve image-guided percutaneous placement of the applicator (i.e. 
catheter, needle) in order to ensure local energy delivery. Another but more 
invasive procedure used in minimally invasive surgery is laparoscopic 
approach. For ablative therapies with heat, the energy deposited in the 
surrounding tissue is adapted to produce tissue coagulative necrosis. The 
extent of the lesion will depend on the thermal dose administered, which 
translates as the final product of high temperature and exposure time, and 
on local tissue interactions that may result in heat lost [19,20].  
Within the area of ablative techniques, RF ablation has proven to be a 
reliable method for creating thermally induced coagulative necrosis and being 
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1.2.  Radiofrequency ablation for minimally invasive surgery 
The earliest use of RF energy in surgery dates back to the early 20th century 
when it was employed for electrocautery and then subsequently applied for 
treatment of cardiac arrhythmias and desiccation of liver tumors [22-24]. It 
was in the early 1900s when the first RF generator was produced, which 
launched the subsequent use of RF energy in medicine. Since then, 
therapeutic applications of RF ablation has been proposed for the treatment 
of cardiac arrhythmias and epilepsy, through hepatic malignancies and 
neoplasms of the kidneys, breast, bone and lungs to assisted resection, apnea, 
pain and aesthetic surgery [3,11,13,15,23,25-27].  
 
1.2.1. Cancer treatment 
Despite a broad field of use, the main interest for RF ablation remains cancer 
treatment presumably due to a reputation for predictable ablation size and 
volume, short ablation time, relatively low complication and morbidity rates 
and suitability to be used on nonsurgical patients [19]. In clinical practice, 
the RF therapy usually consist of a direct and complete tumor ablation with 
a 0.5-1 cm, tumor free surgical margin in order to avoid cancerous cell seeding 
induced by RF catheter displacement or microscopic tumor in the 
surroundings of the primary tumor due to an incomplete of the tumor volume 
[28]. Ideally, a single RF ablation should provide a satisfactory ablation 
volume to accomplish the treatment. In reality, it has been observed that 
tumor sizes greater than 2 cm can be hardly treated with unique RF energy 
application [29]. As a result, in many cases overlapping ablations had to be 
performed. Another issue related with RF-based cancer treatment is 
associated with tumor location and local tissue properties that may affect the 
final outcome by poor accessibility or additional heat losses during ablation 
(e.g. blood flow cooling effect).  
One of the most common cancer types in the world with low survival rate 
and high prevalence of metastasis is hepatocellular carcinoma (HCC). Short 
life expectancy is mainly due to the fact that only 10-20% are candidates for 
surgical resection or transplantation and hence the necessity of local 
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treatments such as RFA [28]. Although its efficacy has been seen on small-
size tumors (<3 cm), the recurrence rate is highly dependent on tumor size 
and therefore for tumors over 5 cm in diameter the successful treatment 
constitutes only 25% of all cases [30]. All those concerns related with cancer 
treatment have produced a growing number of RF catheter designs, method 
improvement or combined therapies (see Section 1.4 Techniques and devices 
for radiofrequency ablation) in aim to increase ablation volumes and enhance 
RF-based cancer treatment performance [31]. 
 
1.2.2. Vascular and ductal sealing 
Radiofrequency ablation is also widely used as hemostatic technique for 
vascular occlusion, as well as endoscopic radiofrequency ablation for the 
treatment of varicose veins or malignant bile duct obstruction treatment, 
usually followed by stent placement (Figure 1a) [32,33]. Endoscopic approach 
requires RF catheters with suitable diameter, flexibility and ability to control 
the temperature necessary for its satisfactory management inside the duct 
and desired ablation volume formation. These parameters as well as any 
complications derived from RF sealing vary depending on the application.  
Venous occlusion has so far shown a high treatment efficacy including the 
long-term studies and is considered a valuable alternative for open surgery. 
Major adverse events concerning vascular surgery involve thrombosis, nerve 
damage and skin burns [34]. Regarding bile duct occlusion, most 
complications can be a result of excessive thermal damage of the surrounding 
structures and cause leaks, hemorrhage or inflammatory responses [35]. Also, 
the risk of tissue adhesion to the electrodes should be considered as it may 
result in tissue disruption while withdrawing the catheter. The bipolar RF 
catheter is a recommended device to use in order to provide uniform and more 
controlled tissue coagulation in a zone surrounding the electrode [36]. 
 
1.2.3. Pain treatment 
 A relatively new technique that employs radiofrequency energy is pulsed 
radiofrequency (PRF) whose effectiveness has been reported in studies for 
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chronic cervical and lumbar radicular pain [37-39]. It is considered a non-
destructive, safe method with reduced side effects in comparison to 
conventional radiofrequency (CRF). Despite of this, some studies 
demonstrated possible risk of heat bursts in a range of 60ºC, which means it 
surpasses the commonly accepted 45-50ºC-lethal temperature [40].  
Although the mechanism of action for pain relief is debatable, it is believed 
that electric fields produced by high-voltage bursts of PRF alter the pain 
signals transmission and possibly also cause electroporation [41]. First 
proposed by Sluijter in 1998, PRF is currently employed typically using the 
standard protocol of a train of 20 ms-long pulses controlled by a temperature 
control unit that limits the maximum tissue temperature up to 42ºC [42,43]. 
Therefore, the total PRF duration is usually longer than of CRF and takes 
⁓120 s. Energy deposition depends on the electromagnetic field distributed 
around the PRF cannula, which is stronger at the tip of the applicator, hence 
the importance of cannula adequate placement to maximize the electrical 
effect on nerve (Figure 1b) [40]. 
 
 
Figure 1. (a) RF catheter for endoscopic treatment of varicose veins, (b) pulsed 
radiofrequency treatment for pain management. 
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1.3. Physics of radiofrequency ablation 
RF energy is a non-ionizing electromagnetic radiation comprised of electric 
and magnetic energy waves oscillating in the frequency range between 3 kHz 
and 300 GHz. For RF ablation of biological tissue, a high-frequency 
alternating current at ⁓500 kHz is used, as it is sufficient to produce frictional 
heating without neuromuscular stimulation and avoid excessive radiation. 
During RF ablation, the catheter is typically inserted interstitially and the 
active electrode in monopolar mode (or both electrodes in bipolar mode) is 
placed in direct contact with ablated tissue. RF current flows through 
electrically conductive tissue between electrodes (or electrode and grounding 
pad attached to the body surface). Energy delivery can be regulated either by 
current (I), voltage (V) or power (P) mode control since they are directly 
related through Ohm’s law, V=I·Z, Z being impedance of tissue in the path of 
current flow (i.e. between electrodes). It is important to note that these 
electrical variables correspond with RMS (root-mean-square) values of the 
waveform employed (sinus). Thus, RF performance strongly depends on the 
properties of the ablated tissue and the surrounding organs, the electrical 
conductivity being the most relevant for RF ablation.  
The electrical properties of tissue vary for different organs and are also 
affected by water and fat content. Tissue hydration is associated with much 
higher electrical conductivity while fat, or adipose tissue, acts as thermal and 
electrical insulator. Among the relatively conductive tissues are the hepatic 
tissues (e.g. liver, kidney, pancreas) whereas less hydrated skin, lungs, breast 
or bones pose more challenge for RF ablation. Additionally, during ablation, 
water evaporation at temperatures near 100ºC causes rapid tissue 
dehydration and loss of electrical conductivity when reached this point. 
The mechanism of tissue heating by RF ablation is initially due to Joule 
heating from the resistive energy loss associated with ionic agitation. Joule 
heating covers only a short distance from the electrode. Deeper tissue layers 
are then heated due to thermal conduction, the process that is slower than 
resistive heating. Final volume of coagulation zone is obtained when the 
electrode-tissue system reaches energetic steady state. However, when 
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energy delivery is interrupted before reaching this state, the temperature of 
previously heated tissue continues increasing for several more degrees, and a 
subsequent lesion growth occurs [44]. This phenomenon is called “thermal 
latency”. 
Tissue coagulative necrosis is based on irreversible cellular damage by 
temperatures typically ranging between 60 and 100ºC, although the 
breakpoint temperature is considered 43ºC [20]. The process can be defined 
by an exponential function according to Arrhenius plot, and different 
exposure times are required for each temperature degree in order to provoke 
irreversible thermal damage. This time-temperature relationship, referred to 
as “thermal dose”, is defined by temperature, exposure time, and tissue type, 
and serves to establish temperature thresholds for thermal damage. Tissue 
coagulation is associated with dehydration at temperatures around 100ºC and 
further charring. It also means that tissue electrical impedance increases 
rapidly, current flow is restrained and thermal lesion growth is impeded. This 
is the main limitation of RF ablation, and to overcome this problem has been 
the main reason for the development of new techniques and applicators. In 
addition to that, another common limitation that decreases RFA efficacy is 
heat sink effect corresponding to energetic loss from the cooling effect of the 
nearby blood vessels.  
 
1.4. Techniques and devices for radiofrequency ablation 
To this date, many RF devices has been studied and developed based upon 
the principles, limitations and applications of RF energy deposition, as none 
of them have proven superior to others. Along with the expansion of RF 
ablation-based treatments into new areas of application followed the 
development of electrode design. There is a distinction between the basic 
plain metal electrodes, internally cooled, expandable, wet or bipolar 
electrodes (Figure 2). Thus, in the context of the electrode, RF device can 
consist of one, multitined or multiple electrodes combined into a cluster of two 
(dual), three (triple), four (quadruple) or more electrodes. Multitined 
electrodes are designed as one expandable electrode inside an insulated 
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needle from which active tines are deployed once the needle is inserted into 
the target tissue.  
Independently of the number of electrodes the setup can involve working 
in monopolar or bipolar mode [45]. In the first case, current flows from one or 
more electrodes of the same polarity toward a grounding pad (also known as 
dispersive electrode or reference patch). Bipolar mode involves two parallel 
inserted electrodes or electrode groups, which avoids the need for grounding 
pads related with the risk of burns. Both systems are currently used in 
different arrangements for multiple purposes depending on the desired shape 
and size of the final ablation volume.   
Apart from varying the electrode shape and number in order to increase 
coagulation zone size, internal cooling (also called closed irrigation) inside the 
RF electrode has been proposed as a method to reduce tissue overheating 
around the electrode [46]. The cooling perfusate, typically saline, circulates 
inside the electrode tip through two hollow lumens, one for introducing 
cooling perfusate and other for the removal of the warmed liquid outside the 
applicator. It can be used in both monopolar and bipolar modes. The design 
has demonstrated a limited improvement in ablation lesion size [46]. 
 
 
Figure 2. Basic designs of RF electrodes: plain, cooled, wet, bipolar, and expandable-
multitined (adapted from [36]). Green zone corresponds with the plastic cover (electrical 
isolation), brown zone represents the created coagulation zone and blue lines correspond with 
the perfusate for open or closed-irrigation.  
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Another approach has taken advantage of saline-enhanced electrical tissue 
properties for greater current flow that would result in a greater ablation size. 
For this purpose, a wet electrode (also called open-irrigated electrode) has 
been proposed by Livraghi et al [47]. The catheter has tiny pores located at 
the electrode that administer saline to the tissue during ablation. The 
technique has also shown an enlarged coagulation zone size with respect to 
the conventional electrode, however, lesion contour is mainly irregular since 
there is no mechanism to control saline distribution in tissue. One proposal 
that addressed this limitation was a hybrid expendable-wet electrode that 




Figure 3. Hybrid RF electrodes: cooled-wet, expandable-wet, bipolar-expandable (upper row 
from the left) and bipolar-cooled, bipolar-wet, bipolar-cooled-wet (bottom row from the left). 
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Another study proposed a model for distance saline infusion that aimed at 
finding the most optimal perfusion distance for the greatest coagulation zone 
volume [49]. Since then, there have been also developed hybrid electrodes e.g. 
cooled-wet electrodes and others that would combine and potentiate the 
effects of both separate applicators (Figure 3) [45,50-52]. 
 
1.5.  Research methodology and theory  
Two main research approaches are being employed in parallel with the same 
aim of studying and optimizing a large number of techniques related to 
thermal ablation therapies including numerous RFA methods: computer 
modeling and experiments. Both are necessary for further advancement in 
the field of minimally invasive therapies. These methods offer different level 
of accuracy, viability and complexity as well as time- and cost-effectiveness, 
and therefore they have become complementary techniques employed in 
medical research and industry. 
 
1.5.1. Computer modeling 
Theoretical models have shown the capacity to predict in great detail 
empirical data that otherwise could be obtained in limited sample size. They 
are useful tools for optimization, maximization of therapy performance or 
personalized treatment using patient-specific parameters. The level of model 
complexity depends on the study requirements and feasibility of simplifying 
the processes, not affecting the results, in order to reduce computational cost. 
Model simplification is also necessary for parameters non-existing in 
literature, poorly described or presenting high variability such as e.g. tissue 
porosity. These uncertainties are an intrinsic attribute of simulation process. 
Subsequently, early numerical simulations considered tissue as homogeneous 
and isotropic, assuming an unchanging blood perfusion rate during tissue 
heating and lack of tissue structural changes at boiling point [53]. 
Most frequently used models for RF ablation consider a two- or three-
dimensional geometry, which include some type of symmetry. These are 
multi-physics models solved by Finite Element Method (FEM) on a 
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macroscopic scale, in which each numerical compartment is represented by 
different tissue.  Mathematical description focuses on electrical and thermal 
effects involved in current and temperature distributions, heat transfer and 
cellular death during lesion formation. These phenomena are described by 
the governing equations including the main governing equation for heat 








                 
(1)
 
where ρ, c, k are the density, heat capacity and thermal conductivity. T stands 
for temperature, Qp and Qm are the heat loss terms for perfusion heat loss 
and metabolic heat, respectively, while q is source therm. A detailed 
expression for heat sink effect from blood flow is as follows: 
)( bbbp TTcωQ                       
(2)
 
where ωb, cb, Tb state for blood perfusion, specific heat of blood and blood 
temperature. The term ωb is usually considered constant during ablation, 
although some studies consider perfusion cessation for thermally damaged 
tissue [54,55]. 
The lesion degree and size can be defined by different models for necrotic 
coagulation. The simplest one focuses on defining a threshold temperature 
above which cells become instantaneously dead. This approach is widely used 
for estimation of in vivo lesion size where the discolored necrotic tissue is 
determined by a 50ºC iso-contour. Although it has been employed in computer 
models, the method lacks in precision since it does not consider the time of 
cellular exposure to high temperatures [56].  
Another method frequently used for modeling is the cumulative damage 


























               
(3)
 
where Ω(t) is the degree of tissue injury, c(t) is the concentration of living cells, 
A is a frequency factor for the kinetic expression, ΔE is the activation energy 
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for irreversible damage reaction, and R is the universal gas constant [55]. 
According to this expression, tissue thermal necrosis is linear with time but 
increases exponentially with temperature. Damage integral is considered 
Ω=1 or Ω=4.6 for 63% and 99% probability of death, respectively. The major 
complication of this method is the need to establish the value A and ΔE, which 
is not an easy task. 
Another models are thermal dose models, which state the thermal dose in 











                       
(4)
 
where t43 is the thermal dose in equivalent minutes at 43ºC, C is a constant 
defined as C=0.5 for ?̅?>43ºC and C=0.25 for ?̅?<42ºC, ?̅? is the average 
temperature during the time interval Δt [58]. The main consideration is that 
the final result of cumulative damage is cellular death, and a lethal thermal 
dose for necrotic tissue the value of t43=240 min is assumed. 
 Resistive heating is computed from: 
EJ q                          
(5)
 
where E is the electrical field obtained from the Laplace equation for 
conductive media [59]: 
0 Vσ                         
(6)
 
where V and σ are the voltage and electrical conductivity, respectively; and J 
is the current density computed from: 
EJ  σ                          
(7) 
At the frequencies employed, tissue can be considered as purely resistive, and 
hence J and E are vectors with the same direction. In terms of numerical 
solving techniques, the accumulation of resistive heating (Joule effect) close 
to the usually thin electrode tip requires a dense mesh in this location and 
therefore higher computational cost. 
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 Temperature changes affect the electrical and thermal properties of tissues 
and they have to be modeled accurately. The ranges of values for material 
properties such as tissue density, specific heat, electrical and thermal 
conductivities, water content or blood perfusion are based on numerous 
experimental studies that characterize their dependency on temperature, 
location and time. However, it is also often related to model variability, which 
can be reduced by performing sensitivity analysis [60]. The way the electrical 
and thermal conductivities are defined and the inclusion of vaporization 
phenomena may also have a huge impact on modeled thermal lesion size. 
Several approaches have considered the temperature dependence of electrical 
and thermal conductivity, however a study showed there was no significant 
difference between these approaches in how they affected thermal lesion size 
[61]. The functions for mathematically modeling electrical conductivity 
always consider a linear or exponential growth until reaching 100ºC when 
vaporization occurs. Above 100ºC a rapid drop of σ value is assumed, 
estimated in several orders of magnitude during the subsequent 2-5ºC or until 
reaching a value close to zero that posteriorly remains constant [62-64]. 
Regarding thermal conductivity mathematical description assumes a 
constant value or a linearly increasing function below 100ºC and a constant 
value for temperatures greater than 100ºC [63,65].  
Finally, Abraham’s formulation also extends the mathematical description 
of vaporization by including the enthalpy method accounting for liquid-to-
vapor phase change. It assumes a three-part formulation for the pre-phase-
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where ρ, c are the density and specific heat, hfg is the latent heat of 
evaporation, Cliq is the concentration of the liquid in the tissue, also called the 
water content. 
 
1.5.2. Experimentation models 
Despite the efforts toward increasing efficiency and reducing research time 
and cost through advancements in theoretical research, experimentation 
modeling remains an essential part of research in order to provide realistic 
testing and validation for the performance and safety of new technologies. 
Numerous studies have therefore been based on phantom and animal models 
or clinical trials. The most controversial practice concerns animal 
experimentation, however presently, no other viable option has yet been 
found to replace testing on animals. Moreover ethical and legal requirements 
have been posed to standardize experimentation procedures and prevent from 
animal abuse.   
Regarding RFA experimentation, phantom and explanted tissue are basic 
models for the ablation study (Figure 4). Their major advantages are low cost, 
availability and also the possibility to produce various ablations using one 
tissue specimen. Subsequently, other organs from the same animal can be 




Figure 4. Example of RFA experiment on liver tissue ex vivo model. 




Figure 5. Example of endoluminal RFA ablation of pancreatic duct with bipolar catheter on 
in vivo pig model. (a) animal sedation (b) opening of the abdominal cavity, (c) cannulation of 
the major papilla, (d) insertion of bipolar RF catheter, (e) postoperatory organ excision and 
the orientational length of the ablated segment.   
 
The most commonly used organs for hepatic ablation study are porcine and 
bovine livers since they are comparable to their human equivalent. No ethical 
approval is required for ex vivo study and the models are usually applied in 
the initial study stages as suitable for comparison of different settings and 
protocols in similar, homogeneous conditions [40,45,48,49]. Ex vivo 
experimentation is naturally limited due to the absence of perfusion-mediated 
tissue cooling and physiological response of a living body. Thus, the extent of 
coagulation necrosis a non-perfused tissue is unrealistic if unaffected by heat 
sink effect or other systemic responses as inflammatory response [1]. They 
are also time-limited since thermal lesions can be examined only at the time 
of ablation with no further evolution over time. Excised tissue is also less 
hydrated and its body temperature decreases to an ambient state; however 
these issues can be further controlled by adequate study setting.  
In vivo model results are usually variable and less reproducible than ex 
vivo models, as they are affected by the presence of the vascular system. For 
experimental procedures, a specialized laboratory facility, legal approval and 
a constant animal care during the study are required. An example of in vivo 
procedure has been shown on Figure 5. Drug administration during surgeries 
including administering anesthesia and surgery, should be performed by 
well-trained personnel, and potential side effects of medication on RF 
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ablation results should be examined. Moreover, possible variability between 
specimens such as weight, sex or age should be considered to avoid 
heterogeneity of study sample. Regardless of these limitations this approach 
provides the opportunity of a follow-up study to examine thermal lesion 
evolution over time and histological analysis [66]. The results can be directly 
transferred to clinical practice as they include all the possible physiologic 
responses that could be observed in humans [47]. Apart from involving blood 
perfusion component, it also enables the employment of more complex tumor 
models, which have been proven to differ in thermal-electrical properties from 
healthy tissues [51].  
Finally, as an alternative to ex vivo and in vivo models, isolated ex vivo 
perfused models were proposed. The excised organ would be perfused using 
autologous blood to maintain physiological and metabolic functions, 
preserving natural organ architecture. The method is considered suitable for 
temporal and histological studies of RF lesions and even for early 
inflammatory response examination. Despite its physiological complexity it 
does not require legal approval and is less costly compared to in vivo 
experimentation. They also offer the possibility of studying the effect of 
perfusion rate modulation in the organ. One of the first models to employ this 
approach was liver perfusion model, which were also typically used in studies 
of metabolism and toxicity, and for RF ablation of a tumor-mimic model [52]. 
Nevertheless, ex vivo perfused models require a relatively freshly excised 
organ from animal under anesthesia and are limited by perfusion lifespan no 
longer than several hours. Another concern is the lack of the interacting 
organs that could be involved in patient recovery and final study result when 
performing the intervention.  
 
The main focus of this work was put on analyzing thermal and electrical 
effects of RFA in the following applications of interventional medicine: pain 
relief, liver tumor ablation and pancreatic remnant management after 
surgical resection. Thus the key objectives could be defined as: (1) 
development of computer models to study electrical and thermal effects of 
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RFA for tissue selective destruction applied in tumor focal ablation and 
surgical resection; and (2) ex vivo and in vivo experimental validation of 
computer models for RFA. Different computer models and experimental 
studies were employed to accomplish these objectives. All computer models 
were built using Finite Element Method by means of COMSOL Software. 
Experimental studies involved agar phantoms, excised liver and pancreas 
specimens for ex vivo study, pig models for in vivo study and clinical trial in 
cancer patients. The main findings of this research have contributed to: (1) 
shedding light on the electrical and thermal effects of different pulsed 
radiofrequency protocols used for pain relief and a possible related nerve 
electroporation, (2) the analysis of a new RF catheter design for an improved 
tissue hydration and a more effective liver tumor radiofrequency ablation, 
and finally (3) proposing and analyzing a new technique of pancreatic duct 
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Chapter 2 
Effect of applied voltage, duration 
and repetition frequency of RF 
pulses for pain relief on 
temperature spikes and electrical 




The thermal and electrical effects of pulsed radiofrequency (PRF) for pain relief can 
be controlled by modifying the characteristics of the RF pulses applied. Our goal was 
to evaluate the influence of such modifications on the thermal and electric 
performance in tissue. A computational model was developed to compare the 
temperature and electric field time courses in tissue between a standard clinical 
protocol (45 V pulses, 20 ms duration, 2 Hz repetition frequency) and a new protocol 
(55 V pulses, 5 ms duration, 5 Hz repetition frequency) with a higher applied electric 
field but a smaller impact on temperature alterations in tissue. The effect of 
including a temperature controller was assessed. Complementarily, an agar-based 
experimental model was developed to validate the methodology employed in the 
computer modeling. The new protocol increased the electric field magnitude reached 
in the tissue by around +20%, without increasing the temperature. The temperature 
controller was found to be the fundamental factor in avoiding thermal damage to the 
tissue and reduced the total number of pulses delivered by around 67%. The 
experimental results matched moderately well with those obtained from a computer 
model built especially to mimic the experimental conditions. For the same delivered 
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energy, the new protocol significantly increases the magnitude of the applied electric 




Radiofrequency (RF) energy is clinically used in pain management. In contrast 
to the wide area of the thermally coagulated zone manifested after continuous 
RF (CRF), pulsed RF (PRF) has demonstrated positive effects on pain 
treatment without provoking any permanent neurological disruptions [1–4]. 
While CRF causes pain relief by the effect of the tissue thermocoagulation 
creating irreversible injury to the target nerve, PRF involves lower 
temperatures (below 42-44ºC), which is considered to be the limit value at 
which no thermally induced necrosis is observed [5][6]. As a result, the PRF 
technique can be applied to the neural regions that have both sensory and 
motor fibers (e.g. peripheral nerves) without any risk of further motor deficits 
[7][8]. 
According to recent studies, there is no definitive explanation for the 
mechanisms involved in PRF. An exhaustive review of experimental 
observations regarding the potential PRF action mechanisms can be found in 
[9]. Different effects of exposure to PRF electrical fields have already been 
reported. Some studies have revealed evidence of morphological changes in 
the neuronal cells after PRF treatment that affect the inner structures of 
axons [1,10–12]. These structural changes consist of mitochondria swelling 
and disruption of the normal organization of the microtubules and 
microfilaments that preferentially affect C-fibers and to a lesser extent Aδ 
fibers. In addition, transient ultrastructural changes such as endoneurial 
edema and collagen deposition have also been found [13]. Besides structural 
changes, the effects on cellular activity and gene expression have also been 
observed [14][15] [1] as well as an increase in the expression of inflammatory 
proteins [12]. All these effects could potentially inhibit the transmission of 
nerve signals through C-fibers, which would lead to pain relief [9]. 
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It is widely accepted that the PRF action mechanism is most likely related 
to the induced electric field, rather than to thermal effects. Several 
explanations of how exposure to an electric field can lead to the observed 
structural effects have been proposed, including: an alteration of the axonal 
membranes due to electroporation [16], an effect on the intracellular 
organelles due to the internal electric field [10] or a long-term depression of 
the synaptic transmission due to electrical stimulation [17]. However, to the 
best of our knowledge, no explanation has been postulated on how the electric 
field can trigger the observed changes in cellular activity and gene expression 
or the anti-inflammatory responses. A recent clinical study (employing a 
temperature control with the upper limit set at 42ºC) reinforces the hypothesis 
that the effects of PRF treatment are probably related to the electric field 
magnitude [18]. 
PRF has usually been based on a train of RF bursts (pulses) with a 10-20 
ms duration and a 1-2 Hz repetition frequency [16],[19]. The application of 
each burst provokes a temperature spike in the electrode tip that could have 
destructive thermal effects. It has been observed from both computer and 
experimental models that the longer pulse durations cause higher 
temperature spike magnitudes [16]. With this idea in mind, a new timing 
pattern consisting of pulses of 5 ms duration and 5 Hz repetition frequency is 
being clinically employed in an attempt to reduce temperature spike 
magnitude [20]. In addition, this new timing pattern is associated with the use 
of higher values of applied voltage (55 V instead of 45 V). Surprisingly, the 
impact of this new protocol (55 V5 ms5 Hz) on temperature spike 
magnitudes and electric field has not as yet been assessed. Although the 
clinical outcome of the new protocol should be assessed by clinical studies, the 
computer modeling technique can be a valuable tool for studying the thermal 
and electrical performance of RF-based clinical techniques. 
With the foregoing considerations in mind, we planned a computer 
modeling study aimed at assessing the differences between the standard 
protocol (SP) (45 V pulses with 20 ms duration and 2 Hz repetition frequency 
[21,22]) and the new protocol (NP) (55 V pulses with 5 ms duration and 5 Hz 
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repetition frequency [20]). An additional protocol (AP) consisting of 45 V pulses 
with 8 ms duration and 5 Hz repetition frequency was also considered, since 
it provides the same energy as the SP (20 ms  2 Hz = 8 ms  5 Hz = 40 ms/s) 
and employs the same repetition frequency as the NP protocol. In this way the 
influence of the pulse duration on both the AP and NP protocols could be 
evaluated. The computer models also included a temperature controller, 
similar to the one implemented in RF generators used in clinical practice, to 
assess the impact of this controlling technique on the temperature spike 
magnitudes and electric field. A complementary in vitro study based on an 
agar phantom was also conducted to validate the methodology used in the 
computational models. 
 
2.3. Materials and methods 
2.3.1. Model geometry 
A PRF procedure was modeled with a 22-gauge needle electrode (0.64 mm in 
diameter) with a 10 mm long exposed tip. Figure 6a shows the two-
dimensional model with three domains, consisting of muscle tissue, plastic 
cover (shaft) and electrode (exposed metallic part). The dispersive electrode 
(patch) was modeled as a zero voltage boundary condition on the outer 
boundaries (see Fig. 6). The optimal dimensions of all the outer boundaries 
were established by means of a sensitivity analysis in which the maximum 
temperature reached at the electrode tip ( MAXT ) was used as the control 
parameter. The dimensions were gradually increased until the difference of 
MAXT  between two subsequent simulations was less than 0.5%, after which 
the dimensions of the previous model were considered to be adequate. 
 
2.3.2. Material properties 
The properties of the materials employed in the model are shown in Table 1. 
Tissue thermal conductivity (k) was assumed to be constant with temperature, 
while electrical conductivity () was modeled as a temperature (T) dependent 
function that grows exponentially +1.5%/°C at temperatures up to 99ºC [23].  
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a  b  
Figure 6. (a) Geometry of the model including tissue, metallic electrode and plastic cover of 
the RF applicator. Dimensions in mm (out of scale). Note the detail of the electrode tip (scale 
in mm) consisting of a conical point with a 10º angle and rounded endpoint with an arbitrary 
0.05 mm radius, which was assumed to avoid an infinite singularity in the model. (b) Specific 
locations chosen for evaluation of time course of electric field magnitude and temperature. 
Eight of these are separated from each other by 2.5 mm (P1P4 in horizontal axis and P5P8 
in vertical axis). SENS corresponds to a point inside the conical tip of the electrode at a 
distance of 1 mm from its tip (TIP). 
 
Assuming that tissue temperature during PRF will stay below 99ºC, no 
desiccation due to water vaporization was modeled. The electrical conductivity 
of muscle tissue (at 37ºC) was set to 0.28 S/m. This led to an impedance 
magnitude of approximately 350  between the needle electrode and the 
dispersive electrode.  
 
Table 1. Electric and thermal properties of materials and tissue [24,36], [37]. 
Material σ (S/m) k (W/m∙K) ρ (kg/m3) c (J/kg∙K) 
Muscle 0.28 a 0.49 1090 3421 
Plastic 10-5 0.026 70 1045 
Electrode 7.4106 15 8103 480 
a This value (at 37ºC) was considered in order to match the simulated initial impedance to 
the clinically observed values (350 , see Section 2.3.2 Material properties). 
σ: electrical conductivity; k: thermal conductivity; ρ: density; c: heat capacity. 
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This same value is typically found during PRF treatment under the same 
conditions as those used in this study and derives from the dielectric 
properties of the different tissues encountered along the path of the electric 
current. This value lies between those reported for muscle (0.45 S/m) and 
nerve (0.11 S/m) [24], and matches well with the physical situation in PRF, 
in which the electrode is inserted into muscle adjacent to a target nerve. 
 
2.3.3. Numerical model 
The computational model was based on a coupled electric-thermal problem. A 
quasi-static approach was proposed for the solution. The governing equation 
for the electrical problem was: 
                      (1) 
where V is the voltage, which is related with the electric field (E) by 
                         (2) 






                 (3) 
where ρ is density of tissue, c specific heat, k thermal conductivity, T 
temperature, t time, q heat source generated by RF power, Qm metabolic heat 
generation (not considered in RF ablation) and Qp heat loss from blood 
perfusion described as: 
)( TTcQ abbbp                       (4) 
where ωb is the blood perfusion coefficient equal to 6.6310-4 s-1 (volume blood 
per unit mass tissue per unit time), ρb and cb are the density and specific heat 
blood of values 1000 kg/m3 and  4180 J/(kg∙K) respectively and Ta is the 
temperature of the arterial blood (37ºC) [25]. The heat source q was taken from 
the electrical problem and evaluated as , where J is the current 
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when tissue reached a 99% probability of thermal necrosis. The degree of 









)(                        (5) 
where R is the universal gas constant, A frequency factor, 3×1044 s-1 and ΔE 
activation energy for the irreversible damage reaction, 2.90×105 J/mol [26]. 
Thermal damage contours were estimated with the isolines Ω = 4.6 and Ω = 1, 
which correspond to a 99% and 63% probability of cell death, respectively. 
Regarding the electrical boundary conditions, no current was assumed on the 
symmetry axis or on the boundary parallel to it (see Fig. 6). Voltage (45 or 55 
V) was set at the electrode and applied as a pulse train, while 0 V was set at 
the boundaries of the tissue perpendicular to the symmetry axis. Thermal 
boundary conditions involved the temperature on external boundaries fixed at 
37°C. No heat flux was considered in the direction transverse to the symmetry 
axis. The initial temperature of the tissue was set to 37ºC. 
Three protocols were considered. While a root-mean-square (RMS) voltage 
of 45 V is typically used in clinical practice with the SP, the NP usually 
involves higher magnitudes, values of 55 V [20] and even up to 60 V [27,28] 
have been proposed. Values of 45 V and of 55 V were simulated here. The value 
of 55 V combined with 5 ms5 Hz is used, since it can deliver an energy value 
comparable to that of 45 V combined with 20 ms2 Hz. This means that 20 
ms2 Hz with 45 V, 8 ms5 Hz with 45 V, and 5 ms5 Hz with 55 V are 
equivalent protocols in terms of energy supplied to the tissue. 
 
2.3.4. Analysis of thermal and electric performance 
To analyze the thermal and electric performance a set of points of interest 
were defined as shown in Figure 6b. Thermal analysis included the 
temperature time course at an internal point of the sharp end of the electrode 
(SENS) and at the electrode point (TIP). For each pulse, the maximum (
MAXT
) and minimum (
MINT ) temperatures reached in the tissue close to the 
64                           Chapter 2. Effect of PRF protocol on temperature spikes and electrical field 
 
electrode tip were analyzed, along with the temperature spike magnitude (
ST
) obtained as
MINMAX TT  . To be more precise, 
MAXT  was the temperature 
measured at the end of each pulse, while 
MINT was the lowest value reached 
just before starting the pulse. In the electric analysis, the RMS (root-mean-
square) value of electric field magnitude (|E|) was assessed at point TIP and 
at eight locations in the tissue, equally distributed across radial (P1 - P4) and 
axial directions (P5 - P8) (see Fig. 6b). These two directions were chosen as 
they are known to have different electric performances [16]. 
 
2.3.5. Temperature controller  
The PRF procedure is habitually conducted with a temperature controller in 
order to avoid thermal lesions in the tissue due to excessive heating [19,29,30]. 
This control is achieved by means of a temperature sensor placed at the 
exposed sharpened tip of the electrode. To keep sensor temperature below the 
threshold of 42ºC, the applied voltage is modified accordingly, either by 
gradually reducing voltage or by transiently switching off the pulse 
application when tip temperature rises above the permitted maximum 
[1,7,10,14,21]. The SENS point shown in Figure 6b was defined specifically to 
mimic the location of the temperature sensor [16]. The temperature control 
was implemented in the model as an algorithm switching the input voltage 
between non-zero (on state) and zero value (off state). The state was 
determined in time by an implicitly defined event for which 42ºC and 41ºC 
measured at the SENS point were temperature set points for off and on states, 
respectively.  
 
2.3.6. Meshing and model solver 
A heterogeneous triangular mesh was used with 5,312 elements and 25,578 
degrees of freedom. A refinement in the area surrounding the electrode was 
applied. Mesh size was determined by a convergence test computed for the 
maximum tissue temperature (
MAXT ) and was gradually increased until the 
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differences in 
MAXT  between simulations were less than 0.5%. The criterion 
used for time step optimization was the difference in temperatures, which was 
required to be less than 0.5°C between two consecutive simulations. The model 
was solved by the Finite Element Method using COMSOL Multiphysics 5.1 
software (COMSOL AB, Stockholm, Sweden). 
 
2.3.7. Experimental validation 
In order to validate the methodology used in the computational model, an 
experimental model based on an agar phantom (0.1% NaCl, dimensions 
86.5×86.5×38 mm) was employed to obtain thermal and electrical 
measurements. Figure 7a shows an overview of the experimental setup.  
A disposable 18G 10-mm RF electrode (St. Jude Medical, Saint Paul, MN, 
USA) was inserted halfway into the agar phantom wall. A 0.1 mm-thick 
transparent polyethylene foil covering the wall of electrode insertion was used 
as an adiabatic window transparent to infrared light. Two varnished copper 
wires (0.19 mm in diameter) were employed as probes to pick up the voltage 
value at 1 mm and 2 mm from the RF electrode surface. The wire tips were 
perpendicularly inserted 0.5 mm into the agar.  
 
a b  
Figure 7. (a) Overview of the in vitro experimental setup based on an agar phantom. (b) 
Geometry of the computer model built to mimic the experimental setup (not to scale). The 
dispersive electrode was modeled on the wall parallel to the wall of electrode insertion.  
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Voltage differences with respect to the dispersive electrode of the RF generator 
were recorded with an Agilent DSO 1000 digital oscilloscope (Keysight 
Technologies, Santa Rosa, CA, USA) at a sampling rate of 1 S/s. A PRF 
protocol of 20 ms × 2 Hz and 45 V pulses was applied during a 2-minute period 
using an RF Neurotherm lesion generator (St. Jude Medical, Saint Paul, MN, 
USA). Temperatures were recorded by FLIR Model E60 infrared camera 
(FLIR Systems, Wilsonville, OR, USA). 
The validation was complemented with a computational model specifically 
designed to mimic the conditions of the experimental setup (see Fig. 7b). Its 
main distinctive features were: three-dimensional geometry, agar electrical 
conductivity of 0.31 S/m, no blood perfusion, ambient temperature of 21ºC, and 
thermal insulation on the walls. The model also considered the presence of the 
voltage recording wires connected to the oscilloscope both thermally and 
electrically. These two wires not only acted as small thermal sinks but, since 
the input impedance of each channel was 20 k at 500 kHz (input impedance 
1 M||15 pF), stray RF current could flow from the electrode through the 
wires and the oscilloscope to the reference point. The model mimicked this 
phenomenon by adding an external circuit to the simulated domain consisting 
of two 20 kΩ resistors, one for each wire. The computer results (temperature 
distributions and progress of the voltage at 1 mm and 2 mm away from the RF 
electrode) were compared to those obtained from the experiments.  
 
 
Figure 8. Time course of the two last temperature spikes (in ºC) at the electrode tip ( TIPT ) 
and inside the electrode ( SENST ) after 6 min for the standard protocol (45 V20 ms2 Hz). The 
time course of SENST  is presented in detail in the additional window. Note that temperature 
spike magnitude (assessed as: 
MAXT  – 
MINT ) was much smaller at the SENS point. 
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2.4. Results 
2.4.1. Thermal performance 
Figure 8 shows the last 2 s of the temperature time courses at points TIP and 
SENS for the SP (45 V  20 ms  2 Hz) for 6 minutes without TC. The courses 
were qualitatively similar at both points and were characterized by abrupt 
rises at the start of each RF pulse and decayed exponentially during off-
periods between consecutive pulses. Table 2 shows the minimal and maximal 
temperatures, along with the temperature spike magnitude computed at both 
points for the three different timing patterns and two voltage values, as well 
as for the cases with and without TC. 
 
Table 2. Minimal (TMIN) and maximal (TMAX) temperatures, and temperature 
spikes (TS) assessed at the tip (TIP) and inside (SENS) the electrode after 6 
min of PRF for different timing patterns (pulse duration  pulse repetition 





45 V 55 V 
TMIN(ºC) TMAX(ºC) TS(ºC) TMIN(ºC) TMAX(ºC) TS(ºC) 
20 ms  2 Hz 
SENS 52.6 54.3 1.7 61.2 63.9 2.7 
TIP 51.3 67.4 16.1 59.2 84.2 25.0 
8 ms  5 Hz 
SENS 53.8 54.5 0.7 60.9 61.8 0.9 
TIP 52.7 61.6 8.9 60.4 73.9 13.5 
5 ms  5 Hz 
SENS 47.4 47.8 0.4 52.9 53.5 0.6 
TIP 46.7 53.2 6.5 51.8 61.7 9.9 
20 ms  2 Hz 
(TC) 
SENS 41.0 42.6 1.6 
 
TIP 40.6 56.8 16.2 




41.0 42.1 1.1 
TIP 40.6 51.1 10.5 
TC: Cases with temperature controller (RF pulses were modulated in order to keep the 
temperature inside the electrode below 42ºC). 
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The main difference between the TIP and SENS points is that the TSENS time 
course was a damped version of TTIP. While 
S
TIPT  varied between 6.5 and 
25.0ºC for all the cases considered, 
S
SENST  only ranged from 0.4 to 2.7ºC. 
Interestingly, the temperatures registered at point SENS were generally very 
close to 
MIN
TIPT  values (differences of 1ºC). 
Figures 9a-9c show the temperature distributions in the zone close to the 
electrode tip for the three protocols (SP, AP and NP) just after the last RF 
pulse in the absence of a temperature controller. As expected, the 
temperature at the electrode tip was maximal just at the end of each RF pulse. 
When the RF pulse ends, heat is evacuated towards the electrode body. 
Similar 
MAX
TIPT  values were found for AP and NP. In contrast, the temperatures 
obtained with the SP were ~6ºC higher and a larger area surrounding the 
electrode tip reached high temperature values. The area of thermal lesion 
(assessed by contour Ω = 1) was similar for the three protocols and measured 
~0.5 mm thick in the direction transverse to the electrode axis. 
 
 
Figure 9. Temperature distributions close to electrode tip just after applying the last RF 
pulse for different protocols without (a-c) and with (d-e) temperature controller. (a) and (d) 
standard protocol (45 V20 ms2 Hz). (b)  additional protocol (45 V8 ms5 Hz). (c) and (e) 
new protocol (55 V5 ms5 Hz). Black line is the damage contour Ω = 1 representing 63% of 
tissue damage. Note that the damage area is similar in (a-c), even though the maximum 
temperature reached in (a) is ~6ºC higher, while no thermal lesion is observed in the cases 
with temperature controller (d-e). 
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Likewise, Figures 9d and 9e show the temperature distributions in the 
zone close to the electrode tip for the SP and NP when the temperature 
controller was considered. As expected, the temperatures in the tissue showed 
the same spatial distribution as in the case with no temperature controller, 
but the absolute values were considerably lower. In fact, no thermal lesion 
was observed in any case. As shown in Table 2, the temperature controller 
kept 
MAX
SENST  at ~42ºC, which meant 
MIN




TIPT  were both reduced by ~10ºC less than the cases with no TC, 
there was a negligible change of ~0.6ºC in the temperature spike magnitude. 
As a consequence, although the TC considerably reduced both the maximum 
and minimum temperatures, it seemed to have no effect on the temperature 
spike magnitude (
S
TIPT  was similar both with and without the TC). Note that 
both 
MAX
TIPT  and 
MIN
TIPT  reached a plateau after ~21 s, which was approximately 
the time when 
MINT  reached 42ºC and the controller came into action. The 




Figure 10. Comparison of time courses of maximal and minimal temperatures between the 
cases with and without temperature control (TC). Temperatures were assessed at the 
electrode tip and correspond with those of the standard protocol (45 V20 ms2 Hz). 
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Regarding the thermal performance of the in vitro experimental study, the 
situation of the temperature evolution at point TA (see Fig. 7b for its location) 
was more or less comparable to that obtained from the corresponding 
computer model, with final temperatures of 26.73 ± 1.63ºC and 29.86ºC, in the 
experiments and simulations, respectively. The temperature measured at TA 
was the maximum value registered by the camera. This value did not 
correspond to the highest temperature (which is usually expected to occur at 
the electrode tip point) since in this study the electrode tip was really 
embedded in the agar phantom. The temperature spikes in the experiments 
and simulations were similar (0.3 ± 0.1ºC vs. 0.2ºC). Figure 11 shows the 
temperature distributions of the experimental and computational models at 
30 s intervals. The shape of the temperature distributions of the computer 
and experimental results was generally similar. While the thermal edge effect 
at the electrode tip was clearly visible in the experimental results (especially 
at 30 s), it was hardly noticeable in the computer results due to the plane view 
selected, which does not include the tip (see Fig. 7b). Moreover, the high 
reflectivity associated with certain metal elements (e.g. electrode and wire 




Figure 11. Temperature distributions from the in vitro experiments (upper) and computer 
modeling (bottom) at different times. Note that the wires designed to pick up voltage in the 
experiments (except their non-insulated ends) are really outside the agar phantom and are 
consequently not part of the material surface.  
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2.4.2. Electrical performance 
The values of the electric field magnitude |E| were quite stable during PRF 
application with no TC (|E| variation was negligible during each pulse). As 
the |E| value is directly dependent on the voltage applied, it was therefore 
higher for NP (55 V-5 ms-5 Hz) than for SP (45 V-20 ms-2 Hz). On this 
account, the |E| value for the AP protocol (45 V-8 ms-5 Hz) coincided with 
those obtained for the SP (45 V-20 ms-2 Hz).  
When the TC was employed, the total number of applied pulses was 
considerably lower than the no TC case, with a reduction of 66.95% and 
67.39% in SP and NP, respectively, while the |E| magnitudes remained 
practically unchanged. This finding suggests that although the tissue 
temperature could have a major effect on |E| through the (T) dependence, 
the spatial temperature gradients are too low to induce significant changes 
in the spatial distribution of  between both models and hence there was no 
alteration in the magnitudes of the electric field. 
 
Table 3. Electric field magnitudes (V/m) measured at specific locations (see 
Fig. 6b) and at the end of the last RF pulse in the case of different timing 
patterns (pulse durationpulses repetition frequency) and applied voltages 
(without temperature controller). 
Applied 
voltage 















1 4,106 4,210 4,165 5,047 5,015 5,047 
2 1,892 1,887 1,837 2,348 2,390 2,318 
3 1,080 1,063 1,022 1,366 1,395 1,292 
4 656 663 633 861 855 805 
5 2,329 2,305 2,237 2,946 2,958 2,807 
6 1,018 1,022 979 1,325 1,323 1,242 
7 612 605 576 789 801 734 
8 413 406 385 532 542 492 
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Figure 12. Electrical potential distribution (V) during the last pulse of the 20 ms pulse 
duration protocol from the computational model based on the in vitro study using an  agar 
phantom (a) and from the modeling study in tissue  (45 V-20 ms-2 Hz) (b). Black contour lines 
represent electric field magnitude (V/m). Black dots are the points of voltage and field 
measurement from each model. 
 
Regarding the spatial distribution of the electric field, the highest |E| 
value for the last pulse was reached at the electrode tip and dropped rapidly 
with distance from the electrode surface, as was also observed with the 
temperature distribution. Table 3 shows the maximum values of |E| at 
various locations. Neither pulse duration nor repetition frequency had an 
impact on the |E| value of the last pulse.  
The |E| value decayed as we moved away from the electrode surface, and 
this drop was stronger in the direction defined by the electrode axis (as shown 
in Fig. 12b). For instance, for SP with 45 V, it decayed from 26.4 kV/m 
(computed at 0.1 mm from the electrode surface) to 4.1 kV/m at P1, and from 
60.9 kV/m (computed at 0.1 mm from the electrode surface) to 2.3 kV/m at P5. 
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For distances from the electrode surface (r) of up to 10 mm, the electric field 
decreased proportionally to 1/r in the direction transverse to the electrode 
axis and to 1/r2 in the direction of the electrode axis. 
In the electrical performance in the in vitro experimental study, the voltage 
values measured at 1 and 2 mm distances at the beginning of the PRF 
application were very similar to those obtained from the computer model: 29.9 
± 3.2 V vs. 29.5 V, and 24.3 ± 2.4 V vs. 24.3 V, respectively. There was also 
good agreement between the values at the end of the application: 30.9 ± 3.0 V 
vs. 30.5 V, and 25.4 ± 2.0 V vs. 25.4 V, respectively. Figure 12b shows the 
voltage and electric field distributions from the computer model built to 
validate the experimental results, which are seen to be very similar to those 
obtained from the model that reproduced the clinical situation (Fig. 12a). 
 
2.5. Discussion 
The aim of this study was to compare the performance of two different PRF 
protocols in terms of the temperature generated and, in particular, the 
electric field. First of all, we conducted an experimental PRF study on agar 
phantom in order to guarantee the accuracy of the computer model 
predictions and validate the modeling methodology. Even though the final 
temperature value was lower in the experiment than in the simulations, we 
found both results in reasonable agreement. One of the possible reasons for 
the measurement interference could have been the effect of the higher than 
expected heat losses, in addition to the fact that the metal electrode had much 
lower emissivity than the agar phantom for which the camera had been 
calibrated. 
The thermal impact of PRF on tissue is defined by temperature spike 
phenomena within a range of independently modified maximum and 
minimum values that depend on the pulse protocol. As previously 
demonstrated by Cosman and Cosman [16], shorter pulses entail lower values 
of the temperature spike magnitude, while higher applied voltage and higher 
repetition frequency imply the opposite. In practical terms, the results 
confirmed that the new protocol (55 V5 ms5 Hz) has a similar thermal effect 
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to that obtained with the standard protocol (45 V20 ms2 Hz) but with a 
considerably higher electric field magnitude due to the fact that both protocols 
provided equivalent total energy during the procedure. 
When the temperature controller was included, the total applied pulses 
were considerably reduced (66.95% and 67.39%). This avoided thermal 
damage to the tissue (Fig. 9d-9e) even though the maximum temperatures at 
the electrode tip were close to 50ºC, neither did it have much effect on the 
electric field magnitude. 
In order to optimize PRF protocols it is necessary to maximize what can be 
defined as the ‘electrical dose’ while minimizing the thermal effects to avoid 
thermal injury, although it is no easy task to define this ‘electrical dose’. 
Experimental studies indicate that it cannot be defined as proportional to the 
delivered electrical energy, because protocols that apply similar heating yield 
different treatment outcomes [18]. Neither can it be defined as proportional 
to the product of the electric field magnitude and the active time (pulse 
duration × frequency) because that would imply that, for protocols of 
equivalent energy but different fields, the protocol with the highest ‘electrical 
dose’ would have the lowest electric field, and experimental results show that 
this is not the case. As it appears that PRF efficacy strongly depends on the 
electric field magnitude, the ‘electrical dose’ should therefore reflect this 
strong dependence on it. By increasing the applied voltage, the target tissue 
is exposed to a higher electric field, but this does not necessarily lead to an 
increase in the delivered energy – or in the thermal effects – if the pulses are 
shortened and the repetition frequency is reduced. 
Since including the temperature controller reduced the total amount of 
applied pulses by 66.95% and 67.39% for SP and NP, respectively, we could 
estimate a ‘cumulative time’ of equivalent continuous electric field application 
as the sum of the duration of all the pulses actually delivered, which would 
provide a ‘cumulative time’ of 4.75 s and 2.93 s for SP and NP, respectively. 
This difference between the protocols should be taken into account in any 
future studies that might prove that the ‘electrical dose’ is somehow related 
to this ‘cumulative time’. 
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Raising the voltage from 45 V to 55 V caused a proportional rise in the 
electric field, which at a distance of 2.5 mm increased to over 500 V/m (along 
the radial axis) and 900 V/m (along the axial axis). As expected, the increase 
in electric field magnitude was approximately proportional to the increase in 
the applied voltage ( +20%). It can therefore be inferred that this increase in 
|E| would have a significant impact on the outcome of the PRF treatment. 
Another interesting finding was that the electric field magnitude shows a 
smaller decrease with distance in the direction transverse to the electrode 
axis, as compared to the direction parallel to it, which suggests that the 
‘electrical dose’ is also affected by the relative positioning of the electrode with 
respect to the target nerve. In the regions close to the electrode tip, the electric 
field magnitude may be large enough to cause cell electroporation. Due to 
their geometry, when nerve fibers are exposed to an electric field with a 
direction approximately parallel to their orientation, the induced 
transmembrane voltage is significantly larger than that experienced by other 
types of cells [31]. Therefore, the electric field necessary for electroporation to 
occur in nerve fibers is lower than in other cells. Although monopolar pulses 
are the most effective in terms of cell electroporation, pulsed AC fields are 
also known to cause it [32], and bursts of biphasic pulses in the same 
frequency range as those used in PRF have been shown to ablate tissues by 
means of irreversible electroporation [33]. 
Due to the lack of experimental studies in this area, it is not possible to 
indicate the electric field threshold necessary for the electroporation of nerve 
fibers to occur when using the typical PRF waveforms, although experiments 
performed with bursts of bipolar pulses can serve as a reference. The electric 
field required to cause electroporation through these pulses is about 2.5 times 
larger than that of conventional monopolar pulses of the same duration [34]. 
On the other hand, in a study by Abramov et al. [35] electric pulses of 7.5 
kV/m caused obvious signs of electroporation and, as a consequence, nerve 
conduction block, as well as disintegration of the myelin sheath and swelling 
of the nerve tissue in the rat sciatic nerve. We can therefore hypothesize that 
severe electroporation will occur in regions exposed to electric fields in the 
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order of 18 kV/m and above, which, in our study, were only found very close 
to the electrode tip (distance < 0.5 mm). Nevertheless, it should be noted that 
this value could have been lower due to the exposure time in PRF treatments 
being longer than conventional electroporation protocols. Neither can we rule 
out the occurrence of mild electroporation – which does not damage neurons 
– for much lower fields. 
 
2.5.1. Limitations of the study 
This study has some limitations that should be pointed out. Firstly, the 
computer model represented a general approach to PRF used in pain 
treatment, but no specific location (target) for the PRF treatment was 
considered, i.e. the tissue was considered to be homogeneous. This 
simplification could introduce inaccuracies in the simulated model since non-
homogeneous tissue presents a distorted electric field distribution. Also, 
instead of modeling different compartments, one material was used in the 
study whose electrical conductivity value was the result of the conductivities 
of the adjacent tissues. Secondly, only one specific RF applicator was modeled, 
regardless of the other sizes habitually employed in PRF clinical practice 
(diameters ranging from 18 to 22 gauges and lengths from 5 to 10 mm). In 
spite of these two limitations, we consider the conclusions are still valid since 
this was a comparative study and the protocols considered were evaluated 
under identical conditions. 
 
2.6. Conclusions 
The recently proposed PRF protocol based on a higher voltage (55 V instead 
of 45 V), shorter pulses (5 ms instead of 20 ms) and a higher pulse frequency 
repetition (5 Hz instead of 2 Hz) can increase the electric field magnitude 
reached in the tissue without raising the temperature as the total time of 
exposure to RF is considerably reduced. However, what really avoids thermal 
damage is the use of a temperature controller, which keeps the electric field 
magnitude at the same level as when this system is absent and reduces the 
total delivered pulses by around 67%. 
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Chapter 3 
A clinically oriented computer 
model for radiofrequency ablation 
of hepatic tissue with internally 




To improve the computer modelling of radiofrequency ablation (RFA) by internally 
cooled wet (ICW) electrodes with added clinically oriented features. An improved 
RFA computer model by ICW electrode included: (1) a realistic spatial distribution 
of the infused saline, and (2) different domains to distinguish between healthy tissue, 
saline-infused tumor, and non-infused tumor, under the assumption that infused 
saline is retained within the tumor boundary. A realistic saline spatial distribution 
was obtained from an in vivo pig liver study. The computer results were analyzed in 
terms of impedance evolution and coagulation zone (CZ) size, and were compared to 
the results of clinical trials conducted on 17 patients with the same ICW electrode. 
The new features added to the model provided computer results that matched well 
with the clinical results. No roll-offs occurred during the 4-min ablation. CZ 
transversal diameter (4.10 ± 0.19 cm) was similar to the computed diameter (4.16 
cm). Including the tumor and saline infusion in the model involved (1) a reduction of 
the initial impedance by 10 - 20 Ω, (2) a delay in roll-off of 20 s and 70 - 100 s, 
respectively, and (3) 18 - 31% and 22 - 36% larger CZ size, respectively. The saline 
spatial distribution geometry was also seen to affect roll-off delay and CZ size. Using 
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a three-compartment model and a realistic saline spatial distribution notably 
improves the match with the outcome of the clinical trials. 
 
3.2. Introduction 
Radiofrequency ablation (RFA) is a minimally invasive procedure that 
destroys tumors by selective heating with radiofrequency (RF) electrical 
current [1,2]. RF current produces ionic agitation in the tissue next to the 
electrode, which is trans- formed into heat and propagated in the tissue by 
thermal conduction [3]. A few seconds after the tissue reaches a temperature 
over 50ºC, the cell proteins are denatured and the cell dies by coagulative 
necrosis [4,5]. To guarantee the destruction of tumor cells, RFA must produce 
a successful coagulation zone (CZ) around the tumor with a 5–10 mm surgical 
margin recommended for inhibition of local recurrence caused by residual 
untreated single tumor cells [6]. Although tissue impedance is reduced when 
heating starts, the dehydration around the electrode due to the liquid-to- 
vapor phase change causes a sudden rise in electrical impedance (roll-off). 
This phenomenon seriously limits energy deposition in the tissue and reduces 
CZ size. Changes in the power delivery protocol and electrode design have 
been the primary ways of overcoming this limitation. 
Internally cooled wet (ICW) electrodes, with combined saline infusion and 
internal electrode cooling, have arisen as an alternative method of increasing 
the CZ size obtained separately by cooled electrodes and wet electrodes [7]. 
The combination of tissue hydration and higher tissue electrical conductivity 
by infused hypertonic saline, together with the effect of internal cooling, keeps 
impedance low for longer and may even eliminate roll-off [8–10]. This 
increases CZ size, and hence the ability to treat larger tumors. Previous 
experimental and computational results have shown that larger CZs can be 
obtained by ICW electrodes than by cooled electrodes and wet electrodes 
separately [11–13], while even larger CZs can be obtained if saline is infused 
2 mm from the mid-point of the electrode tip [14]. This “remote” infusion is 
physically implemented by expandable infusion needles. Unfortunately, 
saline infusion may involve potential risks, such as uncontrolled saline 
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migration in tissue (although this is less likely in the case of encapsulated 
tumors) or irregular CZs [15]. Accidental perforation of the tumor wall by 
expandable infusion needles could also damage nearby organs by saline 
leakage or undesirable tumor cell seeding. 
Computational modelling can provide a comprehensive and detailed 
biophysical description of the electrical and thermal performance of ICW 
electrodes during RFA, and thus can be used to improve their use in clinical 
practice. However, as far as we know, there is still a gap between the 
modelling studies in this field and their transfer to clinical practice [8,13,16–
18]. Demazumder et al. [16] and Antunes et al. [18] built computational 
models of wet electrodes for cardiac and hepatic RFA, respectively, while 
Romero-Méndez et al. [8] compared the electrical and thermal behavior of wet 
electrodes with ICW electrodes. However, all the phenomena associated with 
saline infusion have not yet been thoroughly studied. Although Qadri et al. 
[17] proposed a computational model of ICW electrodes that included saline 
transport through the tissue, neither the ICW electrode model nor the 
ablation protocol (10 min-RFA at constant 90ºC by varying input voltage) 
matched the real conditions of clinical practice. 
As an alternative to the formulation proposed by Qadri et al. [17], we 
recently conducted a study of the influence on CZ size of all the phenomena 
involved in RFA by ICW electrodes and how they could be included in a 
computational model [13]. The results showed that the higher electrical 
conductivity due to saline infusion was mainly responsible for the better 
performance of ICW electrodes over internally cooled (IC) electrodes, 
especially as regards CZ size and delaying roll-off. However, this model had 
two limitations which prevented the computational results being 
extrapolated to clinical practice: (1) the spatial distribution of infused saline 
was assumed to be spherical, which does not always actually occur; and (2) 
the electrical, thermal and perfusion characteristics of healthy and  tumor 
tissue were assumed to be identical, even though electrical conductivity is 
known to be much higher in  tumors than in healthy tissue, and blood 
perfusion in  tumors varies as they grow. 
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Our aim was thus to improve the previous computational model [13] and 
set up a clinically oriented model which would include: (1) a more realistic 
pattern of infused saline distribution at the center of the tumor based on the 
results of an ad hoc in vivo experiment, and (2) three compartments for the 
different zones of saline-infused tumor, non-infused tumor and healthy 
tissue. The computer results (CZ size and evolution of impedance) were 
compared to those obtained from a clinical trial with an ICW electrode with 
identical characteristics to those of the modelled electrode. 
 
3.3. Materials and methods 
3.3.1. Clinical trial 
A randomized clinical trial comparing RF ablation (with ICW electrode) vs. 
microwave ablation (European Registry ISRCTN73194360) is currently 
under way in the Hospital del Mar (Barcelona, Spain). In the context of our 
modelling study, we selected and analyzed only those nodules treated with a 
single RF ablation from May 2014 to April 2017, which involved 17 patients 
and a total of 19 nodules measuring 17.9 ± 0.8 mm in major diameter and 14.8 
± 0.8 mm and 12.8 ± 0.7 mm in minor diameters. RFA was performed using 
an ICW electrode comprised of a single 2.8 mm diameter and 30-mm long 
internally cooled electrode with two electrically isolated expandable needles 
(0.65 mm outer diameter) to infuse hypertonic (20% NaCl) saline at 2 mm 
from the electrode surface [19] (see Figure 13a and 13b). The electrode 
temperature was kept under 10ºC by cooled saline circulating through the 
electrode at 100 mL min-1. RF energy was delivered for 4 min by a CC-1 
generator (Radionics, Burlington, MA). The impedance control mode used 
consisted of a 1-min ramp-up phase followed by 3 min at maximum power 
(~140 W). Power was supplied from the ICW electrode to four dispersive 
electrodes. 
As saline is normally infused during RFA with ICW electrodes, this 
demands that the optimal volume of injected saline must be used, as an excess 
can lead to leaks, irregular morphology of the ablated zones (due to hot saline) 
or seeding of  tumor cells carried by the saline [20]. Alternatively, pre-
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treatment with a hypertonic saline bolus (instead of continuous infusion) 
could provide a controlled dose of fluid and hence would reduce the risk of 
complications. The clinical trial thus employed two boluses of 0.5 mL of saline 
each infused simultaneously through both expandable needles just before 
RFA. Two additional boluses were administered for <15 s after 90 s of RFA 
for additional rehydration of the overheated tissue to prevent any potential 
rise in tissue impedance. Both impedance and power evolution were recorded 
throughout the ablation. After the procedure computer tomography scans 
were used to measure the diameters of the coagulation zones, which were 
“corrected” by taking the shrinkage phenomenon into account prior to 




Figure 13. (a) Internally cooled-wet (ICW) electrode used in the clinical trial. (b) Electrode 
scheme and dimensions (in mm, out of scale). Blue arrows indicate the internal flow of cooling 
liquid while red arrows show the outflow of hypertonic saline through expandable needles. 
(c) Geometry of the three-compartment model used in the computational study. Note that the 
geometry of infused tissue is for illustrative purposes only, i.e. it does not coincide with the 
contour geometry of saline-infused tissue computed from the “generic pattern” (shown in 
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3.3.2. Spatial distribution of infused saline measured by in vivo study 
The spatial distribution of the saline infused into the tissue by the boluses 
was analyzed by means of an in vivo experimental study on two female pigs. 
The study was approved by the Animal and Human Experimentation Ethics 
Committee of the Universitat Autónoma de Barcelona (protocol numbers 
CEEAH 3336 and DMAH 8904). Both animals underwent a laparotomy to 
expose the liver for direct infusion. Iopamidol, a non-ionic contrast agent 
(G.E.S., Madrid, Spain), was added to the infused saline. The boluses were 
introduced into different sections of each lobe through the two expandable 
needles of an ICW electrode identical to that used in the clinical study. Six 
sets of infusions were made, each consisting of two 0.5 mL boluses injected at 
0 s and 90 s, which gives 2 mL total volume injected per set. Each infusion 
took ~15 s. The spatial distribution of infused saline was mapped by a GE 
OEC Fluorostar fixed X-ray image intensifier system (GE OEC Medical 
Systems, Salt Lake City, USA) without applying RF, since the aim was to 
determine the spatial distribution of the saline bolus just before RFA. The 
images were first preprocessed with Image J Software (open source available 
at https://imagej.net), adjusting brightness and contrast in order to reduce 
noise and enhance image quality. As the images from the first and second 
infusion of the same set were seen to have an almost identically shaped and 
sized distribution (see Section 3.4 Results for further details), they were 
overlapped to create a “generic distribution” for each set. The margins of the 
infused areas were then segmented by thresholding each 8-bit greyscale 
image [21], preceded by the background subtraction operation for increased 
effectiveness. The segmented margins were then merged with the original 
images, converted into binary format and mounted together to create one 
greyscale image in which each image made up 16.6% of the total greyscale 
intensity, so that 67% greyscale was considered as the “generic pattern” of 
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3.3.3. Computational model 
3.3.3.1. Geometry 
The computational model mimicked an RF hepatic ablation by ICW electrode, 
as shown in Figure 13a and 13b. The dispersive electrode was modelled as an 
electrical condition on the boundaries parallel to the active electrode axis. The 
area of these boundaries coincided with those of four dispersive electrodes 
(~132 cm2 each). Figure 13c shows the model geometry, which consisted of 
five domains with different characteristics: healthy tissue, non-infused 
tumor, saline-infused tumor, metallic components (electrode, expandable 
infusion needles) and plastic component (sheath). The outer boundaries of the 
healthy tissue domain formed a 60-mm radius and 150-mm long cylinder. 
These dimensions, obtained from a sensitivity analysis, guaranteed an 
adequate distance between the ICW electrode and the boundary condition 
(mimicking the dispersive electrodes) to avoid any effects on the simulation 
results. The reference parameter for the sensitivity analysis was the 
maximum temperature (Tmax) reached after 240 s at five points at <1 mm from 
the ICW electrode. The former dimensions were used in the model for 
differences in electrode Tmax of <0.5% between two subsequent simulations. 
As the three-dimensional geometry presented two symmetry planes (see 
Figure 13c), the computer model only considered one-quarter of the complete 
geometry. The tumor dimensions were based on the nodule size reported in 
the clinical study (see Section 3.3.1 Clinical trial). The tumor was assumed to 
be an ellipse with major axis (axial diameter) of 18.7 mm and with minor axis 
(transversal diameter) of 15.6 mm. The geometry of the spatial distribution 
of infused saline matched with the “generic pattern” obtained from the 
experimental in vivo study (see Section 3.3.2. Saline spatial distribution) and 
was centered and enclosed inside the tumor. This correlated with the 
assumption that saline accumulates inside a tumor with a limited volume due 
to the surrounding fibrous capsule. Any excess saline injected into a tumor 
could result in saline reflux and leakage around the infusion needle 
[20,22,23]. 
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3.3.3.2. Governing equations and conditions 
The model was based on a coupled electric-thermal problem, which was solved 
numerically on COMSOL Multiphysics software (COMSOL, Burlington, MA). 
The governing equation for the thermal problem was the Bioheat equation 










                 (1) 
where q is tissue density, h enthalpy, T temperature, t time, k thermal 
conductivity, q heat source produced by RF power, Qp heat loss by blood 
perfusion and Qm the metabolic heat generation. Qm was not considered since 
it is negligible in RFA. No convection term associated with saline motion was 
considered since its effect is negligible [13]. 
The heat source produced by RF power (Joule losses) was given by 
q=σ|E|2, where E is the electric field. E = −∇V was obtained from the 
governing equation of the electrical problem ∇·(σ(Τ)∇V)=0, σ being the 
electrical conductivity and V the voltage. The electrical conductivity of the 
tissues was assumed to be a temperature-dependent piecewise function: an 
exponential increase by +1.5%/ºC up to 99ºC, the value was kept constant 
between 99 and 100ºC, then reduced two orders for five degrees, and remained 
constant for temperatures above 105ºC. The value of σ was specified for all 
the tissue subdomains considered at a reference temperature (see Tissue 
characteristics subsection). We used a quasi-static approach as it is known 
that the resistive current at RF (≈500 kHz) is much lower than the 
displacement current [26]. 
The blood perfusion term Qp was obtained from: 
)( TTcQ bbbbp                        (2) 
where ωb is the blood perfusion coefficient, ρb and cb are the blood density and 
specific heat, respectively, Tb is the temperature of the arterial blood (37ºC) 
and β is a coefficient that modifies blood perfusion with tissue damage. The 
thermal damage was assessed by the Arrhenius damage model [27], which 
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)(                       (3) 
where Ω is the damage function, R is the universal gas constant, A is a 
frequency factor and ΔE is the activation energy for the irreversible damage 
reaction. The value of Ω = 4.6 corresponding to a 99% probability of cell death 
[28] was used to define the coagulation zone. Accordingly, blood perfusion rate 
was defined as follows: β = 0 for Ω ≥ 4.6, and β = 1 for Ω < 4.6. 
Considering tissue hydration due to saline infusion and vaporization at 
temperatures above 100ºC, the first term in Equation (1) can be expressed in 



































              (4) 
where q and c are tissue density and specific heat respectively at 
temperatures of 100ºC (i=l refers to water in liquid phase) and above (i=g 
refers to water in gas phase), and hfg is the product of water latent heat and 
water density at 100ºC, C is tissue water content, and F is a factor previously 
proposed by the authors which expresses the requirement for more energy at 
the phase change when considering saline infusion, in addition to the water 
already contained in the tissue [13]. 
The thermal boundary conditions were: initial tissue temperature and 
temperature at all the outer boundaries of 37ºC, and null heat flux on the two 
symmetry planes. The cooling effect of the liquid circulating inside the 
electrode was modelled using a thermal convection coefficient h with a value 
of 2,800 W K-1 m-2 and a coolant temperature of 10ºC. The value of h was 
calculated for a flow rate of 100 mL min-1 through an area estimated as half 
of the internal area of the active electrode (see Figure 13b). Electrical 
boundary conditions were: no current flow in the symmetry planes and on the 
top and bottom liver boundaries, and voltage set to zero on the remaining 
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boundary to model the dispersive electrode. Power application mimicked the 
clinical protocol as far as possible: the voltage of the ICW electrode was 
linearly increased from 0 to 74 V during the first 60 s and was then kept 
constant for the remaining 3 min, which corresponded with ~140 W power. 
 
3.3.3.3. Solver 
The model mesh size was predefined by COMSOL at 9.38 mm, although 
additional refinement with 0.6 mm element size was used next to the ICW 
electrode, where the maximal electric and thermal gradients occur. The 
sensitivity study (as previously described for model dimensions) was 
performed on mesh size to find an adequate spatial discretization and 
minimize its effect on the numerical solution. An adaptively changing time 
step was used. Again, we assessed the time-step suitability by an analogous 
sensitivity analysis. 
 
3.3.3.4. Tissue characteristics 
Table 4 shows the parameter values used in the model [29–41]. Healthy liver 
electrical conductivity (σ) was set to 0.2 S m-1 at a reference temperature of 
37ºC, within the range of values reported in the literature: 0.132 S m-1 [29], 
0.143 S m-1 [30] and 0.260 S m-1 [42]. Although a tumor electrical conductivity 
value of 0.5 S m-1 had been used previously [20,30,31,42,43], 0.45 S m-1 was 
chosen so that the computed initial impedance evolution matched the values 
found in the clinical trials (Section 3.4.1 Clinical trial). 
Saline-infused tumor was characterized by higher electrical conductivity 
due to the increased concentration of ions in the saline, which carry the 
electric charge. According to Goldberg et al. [23], tissue “doped” with 18% 
hypertonic saline showed almost half the impedance measured before the 
injection (~110 Ω before and ~64 Ω after). This can only be due to higher 
electrical conductivity, and so the electrical conductivity was twice that of 
non-infused tissue: 0.4 S m-1 for saline-infused healthy liver and 0.9 S m-1 for 
saline-infused tumor. This assumption led to lower initial tissue impedance 
and matched the clinical values (see Section 3.4.1 Clinical trial). 
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Table 4. Characteristics of the materials used in the computational model 
(ref. in brackets). 


















70 [35] 8·103 [35] 
1080 [29] 1045[31] 1045 [31] 





1045 [35] 480 [35] 
3455 [29] 3760 [31] 3760 [31] 
GP 2156 [29] 2156 [29] 2156 [29] 
Water content 
(%) 
  68 [37] 84 [38, 39] 84 [38, 39] 
Frequency 
factor (s-1) 
  7.39·1039 [40] 5.316·1050 [41] 5.316·1050 [41] 
Activation 
energy (J/mol) 
  2.577·105 [40] 3.238·105 [41] 3.238·105 [41] 
Blood 
perfusion (s-1) 
  0.016 [30] 0.009 [30, 33] 0.009 [30, 33] 
Electrical conductivity of tissue was measured at 37ºC; LP: water in liquid phase; GP: water 
in gas phase. 
 
Values of tumor density (ρ) and specific heat (c) when its water content is 
in the liquid phase (T < 100ºC) were taken from [29] and [31]. However, as to 
our knowledge there are no references for the value of tumor density and 
specific heat when its water content is in the gas phase in Equation (4), we 
assumed the same values as liver, due to their similarity in this state and 
their slight influence on the results [44]. 
As tumor blood perfusion coefficient (ωb) has been reported within a wide 
range of values: 0.0027 s–1 [32], 0.0053 s–1 [43], 0.0069 s–1 [45], 0.0096 s–1 [33], 
0.011 s–1 (63.8 mL/100g min–1, [46]) and 0.009 s–1 (510 mL kg–1 min–1, [30]), 
we chose a value of 0.009 s–1 as it was the reference we used for healthy tissue 
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and agreed with Aramburu et al. [45], who suggested that perfusion in 
healthy tissue is different from that of  tumor tissue. While healthy tissue is 
supplied through the portal vein and hepatic artery, a tumor is exclusively 
supplied from the hepatic artery, which could mean the blood perfusion rate 
is higher in healthy tissue than in the tumor. We therefore used a value of 
0.016 s–1 for healthy tissue, which has also been also reported in the literature 
[30]. According to Hall et al. [44] the perfusion coefficient has a strong impact 
on the model results, so we decided to conduct a sensitivity analysis of ωb 
values for tumor (Case F) ranging from 0.0027 s–1 to 0.011 s–1. 
Factor F in Equation (4) was set to 1 for both non-infused liver and 
tumor. For the saline-infused tumor we used a value of F = 3 obtained by a 
sensitivity analysis, as suggested in [13], which related the given value with 
the process of tissue hydration. F was an adjusting parameter for energy at 
the phase change during water evaporation when considering saline infusion, 
as it is assumed that additional tissue hydration increases the tissue’s heat 
capacity. As the only references for characterizing saline-infused tumor, deal 
with its electrical conductivity, we used the same material characteristics as 
for non-infused tumor. 
 
3.3.3.5. Cases analyzed 
The aim of this study was to improve a previously proposed computational 
model [13] by including two clinically oriented characteristics: (1) a more 
realistic spatial distribution of infused saline, and (2) new geometry with 
three separate compartments for healthy liver, non-infused tumor and saline-
infused tumor. To assess the influence of these two characteristics on the 
results, the following five cases were solved and their results compared: 
- Case A: One-compartment model considering only non-infused healthy 
tissue (for an IC electrode). 
- Case B: Two-compartment model consisting of non-infused and infused 
zones of healthy tissue, assuming spatial distribution to be spherical [13]. 
- Case C: Two-compartment model as in B but using the “generic pattern” of 
saline distribution obtained from the in vivo experiments. 
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- Case D: Two-compartment model consisting of non-infused healthy liver and 
tumor tissue. 
- Case E: Three-compartment model consisting of healthy tissue, non-infused 
and infused tumor with the spherical saline distribution as in Case B. 
- Case F: Three-compartment (full) model consisting of healthy tissue, non-
infused tumor and infused tumor with the “generic pattern” of saline infusion 
obtained from the in vivo experiments. 
 
3.3.3.6. Outcomes 
Impedance evolution throughout ablation was analyzed for each case, as was 
transverse CZ diameter at roll-off or otherwise at 240 s. The CZ computed by 
the Arrhenius damage model at 4 min produced a “very noisy” contour. 
According to Schutt et al. [28], when computing the lesion dimension contour, 
the 48–50ºC isotherm correlates with the D99 thermal damage contour, which 
corresponds to Ω = 4.6 (99% probability of cell death) after a 12 min protocol. 
In the present study we verified that after 4 min of ablation the 50ºC isotherm 
matched with Ω = 4.6 (with variations <2 mm) but the isotherm traced a more 
regular line, so that the 50ºC isotherm was used to measure CZ diameter. 
Obviously, the use of the isotherm impedes computing the thermal damage 
accumulated during the cooling phase (just after RF power is switched off), 
although it is known that the difference in CZ size before and after the cooling 
phase is negligible in long ablations [47]. Because of the shrinkage associated 
with RFA, CZ size as measured in clinical practice could be up to 12–20% 
smaller [48,49]. According to Schutt et al. [28] and Rossmann et al. [48], it is 
preferable to compare computational results with those obtained in the 
clinical trials before shrinkage. We therefore established a 20% bigger CZ size 
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3.4. Results 
3.4.1. Clinical trial 
A maximum output power (140 W) was applied to the tissue after a 1 min 
ramp-up, which implied ~30 kJ of total energy deposited. The initial 
impedance value was ~55 Ω, and dropped to a value of 46 ± 6 Ω just after 
saline infusion and kept more or less constant throughout the ablation 
(plateau phase). No roll-off was registered in the whole period. The measured 
CZ diameters were 3.42 ± 0.16 cm and 2.81 ± 0.16 cm (maximum and 
minimum transverse diameters, respectively) and 4.71 ± 0.19 cm (axial 
diameter). After discarding the shrinkage effect and considering 20% larger 
diameters, these values were: 4.10 ± 0.19 cm and 3.37 ± 0.19 cm (maximum 
and minimum transverse diameters, respectively) and 5.65 ± 0.23 cm (axial 
diameter). 
 
3.4.2. Saline spatial distribution 
The six sets of infusions gave a total of 12 saline distributions (one per each 
infusion needle). In most cases (10/12), during the injection of the first bolus, 
X-ray images showed the saline gradually occupying the space around the 
needle outlet, until a volume of infused tissue was formed. After the injection, 
the intensity of the contrast agent associated with the saline presence was 
seen to drop steadily for 90 s, but did not completely disappear. The shape of 
the infused volume remained unchanged during this period. During the 
administration of the second bolus, the intensity was gradually restored and 
the shape contour expanded slightly, after which the intensity and shape 
evolution were similar to those of the first injection. 
In a few cases (2/12) the X-ray images showed that the infused saline 
escaped through preferential paths and could not accumulate around the 
infusion needle. These paths corresponded with nearby vessels, whose 
presence significantly weakened the intensity associated with the contrast 
agent. As the same procedure occurred after the second bolus both cases were 
discarded in the analysis. 




Figure 14. (a) Images of saline spatial distribution from the six saline injection trials (1 – 6) 
conducted on the in vivo model. Saline presence is shown in white, while electrode, infusion 
needles and non-infused tissue are in black. (b) “Generic pattern” of saline spatial 
distribution derived from the six images from (a) by thresholding and merging them into one 
greyscale image. (c) Contour geometry of saline-infused tissue derived from the “generic 
pattern” in (d) and used in the computer model. 
 
In the remainder (10/12) the saline distribution was irregular and mostly 
accumulated close to the expandable needle outlet. Figure 14a shows the 
overlapped images of saline distribution obtained from the six sets of saline 
injections used to obtain the “generic pattern” shown in Figure 14b. 
The contour geometry used in the computer model was derived from this 
“generic pattern” and revolved symmetrically to the rotation axis (Figure 
14c). The total volume of saline estimated from the computer model was close 
to the total volume injected during each in vivo experiment (1.62 and 2 mL, 
respectively). This volume was used to estimate the radius of the saline 
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3.4.3. Computational results 
3.4.3.1. Impedance evolution 
Figure 15 shows the impedance evolution for each analyzed case. Roll-off was 
earlier in cases without saline infusion (A and D), while the addition of saline 
involved a delay of around 70-100 s (B and C). Roll-off occurred earlier in Case 
B, with spherical distribution, even though both cases considered the same 
saline volume. Although including the tumor involved a delay in roll-off (see 
case A vs. D), its effect was not as marked as saline infusion. In contrast, no 




Figure 15. Impedance evolution in the six analyzed cases: A (one-compartment model, only 
liver), B (two-compartment model, with liver and saline-infused liver using the saline 
distribution with spherical geometry as proposed in [13]), C (two-compartment model, with 
healthy liver and saline-infused healthy liver using the saline spatial distribution obtained 
from the in vivo experiment), D (two-compartment model, with non-infused healthy liver and  
tumor), E (three- compartment model, with healthy liver,  tumor with non-infused and saline-
infused zones, and spherical geometry infusion) and F (three-compartment model, with 
healthy liver,  tumor with non-infused and saline-infused zones, and saline spatial 
distribution obtained from the in vivo experiment). The horizontal grey band represents the 
range of impedance values observed in the clinical trial. Roll-off time is shown for cases A, B 
and D. 
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Comparing the cases with and without saline infusion (B, C, E and F vs. A 
and D), infusion was seen to reduce the initial impedance from 69 Ω to 60 Ω 
in the cases considering only healthy tissue (A vs. B and C) and from 56 Ω to 
50 Ω in the cases including the tumor (D vs. E and F). In other words, saline 
infusion reduced the initial impedance by ~10-13%. Comparing the cases with 
and without the tumor (A, B and C vs. D, E and F), when the tumor was 
included the initial impedance was reduced from 69 to 56 Ω for non-infused 
tissue (A vs. D) and from 60 to 51 Ω for saline-infused tissue (C vs. E and F), 
showing that the presence of the tumor reduced initial impedance by 15–18%. 
Because of the delay in roll-off, the cases that considered both saline 
infusion and tumor (E and F) had the longest plateau phase, with impedance 
values more or less constant and within 32 - 50 Ω, and even up to the end of 
ablation in Case E. Interestingly, the case with the saline distribution based 
in the “generic pattern” (F) showed values closer to those observed in the 
clinical trials. 
 
3.4.3.2. Joule heat source distribution 
Figure 16 shows the comparison of the Joule heat source distributions in cases 
A–F at the beginning of ablation, at 1 s.  
 
 
Figure 16. Joule heat distribution in the tissue for cases A–F at 1 s of ablation, (logarithmic 
scale in W/m3). Note that maximum values are reached only on the electrode surface and the 
infusion needles. 
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As expected, the highest Joule heating concentration was seen in close 
proximity to the electrode and reached its maximum at both ends of its active 
part. Although the metal infusion needles were not part of the active electrode 
(since they are not electrically connected to it), there was a noticeable 
accumulation of power distribution along their length. Higher power intensity 
(values ~109 W m-3) was also observed in Cases B–F along the boundaries of 
the tumor and saline domains, although it was slightly lower within these 
domains (~107 W m-3). 
 
3.4.3.3. Coagulation zone size 
Figure 17a shows the temperature distributions, CZ contour (assessed by the 
50ºC isotherm), 100ºC isotherm, and the values of transversal CZ diameter 
for the six analyzed cases.  
 
 
Figure 17. (a) Temperature profiles of cases A–E. Black and white contours are 50ºC and 
100ºC isotherms, respectively. The transversal diameter value and time of acquisition are 
shown in all cases at roll-off times before 240 s or at 240 s in the absence of roll-off. (b) Detail 
of electrode zone in (a) with 100ºC white isotherm shown. 
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The largest transversal CZ diameters were observed when saline infusion was 
considered. The diameter increased from 2.60 cm to 3.54 - 3.60 cm in healthy 
tissue (A vs. C and B, respectively) and from 3.40 cm to 4.16 - 4.34 cm in the 
tumor (D vs. F and E, respectively). Although all the cases showed a similar 
CZ shape, saline infusion increased the transversal CZ diameter by 37% in 
healthy tissue and 25% in tumor tissue. 
Including the tumor as a single factor also increased the transversal CZ 
diameter by 31% in non-infused tissue (A vs. D) and 18 - 20% in saline-infused 
tissue (B vs. E and C vs. F). Interestingly, the results showed that including 
either saline infusion (B and C) or tumor (Case D) produced a similar increase 
in the transversal CZ diameter. As a logical consequence, the largest 
transversal CZ diameter was obtained when both characteristics (saline 
infusion and tumor) were considered together (E and F). 
 
3.4.3.4. Effect of tumor blood perfusion 
The analysis of the effect of different  tumor blood perfusion values (ωb) on 
the three-compartment model (Case F) showed that in 240 s of ablation roll-
off appeared only when the ωb value was the lowest of the chosen range 
(0.0027 s–1). For higher blood perfusion values used it was assumed that roll-
off would occur after 240 s and would depend on the ωb value. CZ growth 
during the 240 s ablation in all the models was practically unchanged for 
different ωb values (differences <1%), showing that increasing the ωb value 
did not directly increase CZ size but could delay roll-off. 
 
3.4.4. Comparison of clinical and computer results 
Figure 18 shows the transversal CZ diameters obtained from the computer 
results and clinical trials. The colored band represents a range between a 
minimum value which considers the tissue shrinkage effect and a minimum 
value that does not, or the probable range in which the results of the computer 
model (which did not consider the shrinkage effect during ablation) could be 
compared to the results of the clinical trials.  
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Figure 18. Transversal diameters of the coagulation zones computed for the considered cases 
A–F. Horizontal lines are the mean transversal diameter found in the clinical trials (dashed 
line) and the “corrected value” by taking the shrinkage effect into account (dotted line). The 
colored band thus represents the range in which the clinical and computed results would 
match. 
 
It can be seen that only the cases that included both saline infusion and the 
tumor (E and F) predicted a higher transversal diameter than the minimum 
value. Only Case F was strictly within the diameter range and therefore the 
only case with similar results to those of the clinical trials. 
 
3.5. Discussion 
This study was designed to go a step further in RFA computer modelling by 
ICW electrode. The desired improvement was to be obtained by including two 
clinically oriented characteristics: a more realistic geometry of the infused 
saline spatial distribution and assigning specific characteristics to infused 
and non-infused tumor zones. 
First of all, an in vivo study was performed on healthy porcine liver to 
determine saline spatial distribution after a bolus injection. Two results were 
obtained, possibly depending on the tissue morphology around the infusion 
point. First, when the infusion point was at a certain distance from a vessel, 
the parenchyma retained a certain amount of saline around that point, at 
least at the infusion rate employed here (1 mL for 15 s). The space occupied 
probably depended on the bolus volume. The gradual decrease in image 
intensity indicates that there is a slow loss of accumulated volume, which 
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suggests that the tissue morphology allows the saline to migrate away, 
possibly through central veins. This suggests that some saline is still present 
prior to the second bolus and it is hence reasonable to assume that just after 
the second injection there will be between 1 and 2 mL of saline around the 
needle. For this reason, the estimated 1.62 mL of total volume of infused 
saline in the computer model can be said to be consistent. 
Second, when the infusion point was near a vessel the results suggested 
that the vessel acted as a preferential saline drainage path. Under these 
conditions, no saline would be retained around the infusion point and the 
tissue would not be rehydrated during RFA. 
The “generic pattern” used to build the computer model geometry was 
based in the most probable scenario, i.e. that allowing saline to accumulate 
around the infusion point. In fact, although the saline distributions indicated 
dispersion between the injections, the “generic pattern” matched 67% of the 
observed cases, showing irregular borders around the electrode and infusion 
needles, possibly due to heterogeneous permeability caused by the presence 
of branching networks of blood and lymphatic vessels [50]. 
The thin laceration gap during electrode insertion between the tissue and 
metal components (infusion needles and electrode) could also form an 
additional preferential saline drainage path. However, this behavior was not 
found during the study, nor did we find any previous publications reporting 
this issue. This phenomenon was therefore discarded in the model. The in 
vivo study thus suggests that saline mainly accumulates around the needle 
outlets in an oval-like geometry with the largest diameter in the direction of 
the electrode axis. Because it is reasonable to assume that saline distribution 
during RFA would be different in the presence of a tumor (see Limitations), 
the “generic pattern” employed to build the geometry of the computer model 
should be considered an approximation. 
The computer results showed that modifying the simplest model (Case A) 
to include a second compartment (tumor or infused zone) reduced the initial 
impedance. This can be explained by the electrical conductivity of both saline 
and tumor being higher than non-infused healthy tissue. This also meant that 
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for the same RFA protocol the initially applied power in Cases B, C and D 
was ~20 W higher than A, which could have been responsible for the larger 
CZ in those cases. However, the authors consider that the most important 
factor in CZ growth is the delay in roll-off: ~23.5 s when the tumor is included 
(D vs. A) and up to 72.3 and 98.6 s when an infused tissue zone is considered 
(B and C vs. A). The larger CZ size due to only including the tumor in the 
model has already been reported by Ahmed et al. [32], although in the present 
study the greatest effect was related to saline infusion, and hence to tissue 
hydration, by including factor F in the mathematical framework. This factor 
is simply an adjusting parameter which allows an energy increase to be 
considered at the phase change in response to additional tissue hydration by 
saline infusion, which increases the tissue’s heat capacity. This, in addition 
to the increase of electrical conductivity, explains the long roll-off delays. Two-
compartment models thus predict larger CZs than models based exclusively 
on healthy tissue. 
One of the innovations of this study was to include a specific geometry for 
the infused saline zone based on the results of an in vivo study. Despite the 
limitations involved, we considered this to be the most plausible 
representation of the spatial distribution of saline in the tissue. As compared 
to a spherical distribution [13], the geometry derived from the “generic 
pattern” (Case C) extended roll-off time by 26 s. Because both geometries 
involved the same total saline volume, the delay could be explained by the 
particular geometry of case C, which tends to completely surround the 
electrode, extending toward the ends in an elongated shape, in contrast to the 
spherical geometry in Case B. The electrode ends (tip and proximal edge) are 
associated with the hot points around the electrode and if covered by saline 
affect the temperature distribution around the electrode, including the 100ºC 
isotherm ring closure that precedes roll-off. This geometry is also probably 
responsible for the CZ diameter being 0.06 cm smaller than the spherical 
geometry, as its radial distance was slightly smaller than the spherical 
radius. This difference was higher (0.18 cm) when both geometries were 
compared in the models that included a tumor (E and F). 
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Additional observation of the Joule heat source distribution showed that 
the metal infusion needle could act as a passive electrode by focusing the 
electrical current and hence “build” a radius of a greater power deposition 
than would be the case with only the active electrode working. This could 
therefore affect the current distribution in tissue and the volume of the power 
deposition by the Joule effect. The temperature profile and the CZ size could 
therefore be increased by this factor. Also, a higher power intensity seen at 
the borders of the tumor and saline domains would suggest that the power 
deposition occurs faster at the borders than within the domain but since this 
difference does not correlate with the corresponding temperature distribution 
this hypothesis is discarded. Thus, the most likely reason would be the 
boundary effect produced between two neighboring domains with different 
electrical properties (see cases A vs. B–D and B–D vs. E–F). 
Apart from the small differences between cases E and F, the general 
conclusion is that the three-compartment models offered the most similar 
results to those of the clinical trial in terms of impedance evolution (see 
Figure 15) and CZ diameters (see Figure 18). 
 
3.5.1. Limitations of the study 
Because the in vivo study did not consider application of RF power nor tumor 
tissue we cannot be certain of the saline distribution in these circumstances. 
However, it is generally accepted that a tumor has an unorganized, disfigured 
and leaky vessel network with insufficient blood supply, so that its vessel 
system seems unlikely to be a preferential path of saline drainage [51]. The 
authors consider that saline would tend to accumulate in the tumor, or at 
least there would be no significant mechanisms to drain saline away from the 
tumor, which would justify the assumption of static saline distribution in the 
model. This is in line with the observations during the clinical trials on actual 
cases of hepatic tumors, in which no roll-offs occurred after the bolus 
injections, unlike RFA with saline infusion on healthy tissue. 
We recognize that RF-induced heating could affect tissue properties and 
modify saline distribution. First of all, protein denaturation is known to 
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increase tissue permeability in the ablated region, but this may not be the 
case further away from the electrode. This would imply saline migration to 
more permeable regions. However, the denatured tissue surrounding the 
electrode would shrink, allowing saline retained at the more permeable zone 
to move closer to the electrode. There is also a possibility that the nearby 
blood vessels would narrow or close completely due to the high temperature 
and eliminate this preferential saline path. In other words, during RFA the 
saline distribution could change due to vaporization but would remain in the 
area of infusion as there would be no paths for the saline to drain. 
The computer model did not consider the possible additional thermal 
damage associated with vapor migration after the boiling of interstitial 
liquids, which can affect CZ size [52]. The increased vapor volume means that 
in order to stay in thermodynamic equilibrium it needs to expand to maintain 
the same interstitial pressure, as otherwise, if the volume is constrained, the 
pressure would increase and the saline could move away from this region. In 
any case, hot saline transport or vapor migration could engender substantial 
damage in the surrounding tissue [52] and consequently would modify the CZ 
size. This phenomenon has been reported to be important in cases with high 
energy delivery (>100 kJ) for a long period (>30 min) [52]. Because in our case 
the delivered energy was ~30 kJ, we consider that the pressure level was not 
high enough to cause significant saline or vapor migration. 
It is also important to point out that the factor F used in this study did not 
really model the specific phenomena triggered by tissue hydration, such as 
the higher tissue heat capacity, the latent heat throughout ablation and 
therefore the longer energy release during the phase change. In this light, its 
use has no physical explanation. Instead, it was included simply as an 
adjusting parameter whose value was obtained in a previous study by means 
of sensitivity analysis, in response to the greater energy requirement when 
considering saline infusion [13]. The phase change due to water vaporization 
could also be modelled using the apparent heat capacity method, which 
defines the increased heat capacity over a transition phase as a function of 
temperature. This would describe the evaporation mechanism more precisely 
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and would be more suitable for modelling vaporization with this type of 
electrode. On the other hand, neither the enthalpy method nor the apparent 
heat capacity method includes the effect of vapor heat migration, since they 
assume it to be small. Our approach simplifies the model by simply adjusting 
the value of the energy at the phase change at 99ºC instead of defining the 
transitory state. Neither does it increase the computational requirements, as 
in the apparent heat capacity method that uses smaller time step and greater 
mesh refinement. 
With regard to the model, the axial symmetry could be a limitation as it 
involved using the same value for both transversal diameters of the modelled 
tumor. Although real tumor nodules present three different axis diameters, 
the results are still valid since we used the same diameter for both modelling 
the tumor and assessing the CZ diameter. 
 
3.6. Conclusions 
Our experimental findings suggest that the saline spatial distribution in 
healthy tissue is not necessarily spherical. In fact, saline tends to cumulate 
around the outlets of the infusion needles, forming an oval-like geometry with 
the largest diameter in the direction of the electrode axis. The computer 
modelling study suggests that the inclusion of a second compartment (tumor 
or infused saline) involves a reduction of the initial impedance and larger 
coagulation zone size than a one-compartment model based on healthy tissue. 
The only results similar to the clinical trials were obtained from the three-
compartment models (including healthy liver, tumor with non-infused and 
saline-infused zones) in terms of impedance evolution and CZ diameters. 
Adding these two features could thus help to develop a more precise and 
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Chapter 4 
Development of a catheter-based 
technique for endoluminal 




Endoluminal sealing of the pancreatic duct by glue or sutures facilitates the 
management of the pancreatic stump. Our objective was to develop a catheter-based 
alternative for endoluminal radiofrequency (RF) sealing of the pancreatic duct. We 
devised a novel RF ablation technique based on impedance-guided catheter pullback. 
First, bench tests were performed on ex vivo models to tune up the technique before 
the in vivo study, after which endoluminal RF sealing of a 10 cm non-transected 
pancreatic duct was conducted on porcine models using a 3Fr catheter. After 30 days, 
sealing effectiveness was assessed by a permeability test and a histological analysis. 
The RF technique was feasible in all cases and delivered 5 W of power on an initial 
impedance of 308  60 Ω. Electrical impedance evolution was similar in all cases and 
provided guidance for modulating the pullback speed to avoid tissue sticking and 
achieve a continuous lesion. During the follow-up the animals rate of weight gain 
was significantly reduced (p<0.05). Apart from signs of exocrine atrophy, no other 
postoperative complications were found. At necropsy, the permeability test failed 
and the catheter could not be reintroduced endoluminally, confirming that sealing 
had been successful. The histological analysis revealed a homogeneous exocrine 
atrophy along the ablated segment in all the animals. Catheter-based RF ablation 
could be used effectively and safely for endoluminal sealing of the pancreatic duct. 
The findings suggest that a fully continuous lesion may not be required to obtain 
complete exocrine atrophy. 
 




Sealing of the pancreatic duct is used to manage two main pancreatic 
malignancies: pancreatitis and pancreatic ductal adenocarcinoma [1]. Sealing 
is usually achieved either by ligation of the affected pancreatic duct to 
eliminate pancreatic secretions or tumor resection followed by anastomosis of 
the remaining pancreatic stump [2,3]. However, the common problem of 
leakage of the pancreatic contents into the abdomen, also known as 
pancreatic fistula, can affect patient morbidity and mortality during the 
postoperative period. Many studies have explored feasible techniques for 
sealing the pancreatic stump in order to replace anastomosis and minimize 
the risk of leakage [4]. Sutures, staplers, clips or endoluminal glue injections 
are some of the most frequently used tools currently used in clinical practice. 
However, none of these techniques has been proven to effectively reduce the 
high risk of failure in these cases. 
Radiofrequency ablation (RFA) is one of the recently explored sealing 
techniques. In this case the action mechanism does not rely on introducing a 
sealing agent, but on inducing epithelial necrosis to trigger fibrosis 
(cicatrization) and collagen shrinkage and cause ductal atrophy. Our research 
group had already examined the effect of pancreatic stump closure by RF-
assisted transection in terms of fistula formation on rat and pig models [57]. 
The results showed that RFA not only induced exocrine atrophy for ductal 
occlusion but also reduced the occurrence of fistula. These findings 
encouraged us to go beyond the transection plane and consider extending RFA 
endoluminally along a segment of the pancreatic duct itself.  
The concept of endoluminal thermal ablation is not really new since it has 
already been used in clinical applications for vascular occlusion such as e.g. 
hepatic tumor arteries, varicose veins [8,9] and biliary tumors [10]. However, 
to our knowledge, there is no evidence that this technique has been previously 
employed for pancreatic remnant sealing, as proposed here. As in the case of 
glue, the main purpose of thermal coagulation of the duct walls is to prevent 
leakage by sealing the secretory ducts along its walls and inducing ductal 
atrophy and also ensure the loss of ductal permeability. In order to efficiently 
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perform endoluminal ablation of the pancreas, a thermal coagulation zone 
should meet the following characteristics: 1) it should be long enough to suit 
the remnant pancreas after a resection; 2) be as contiguous as possible, i.e. 
with the minimum number and length of gaps; 3) there should be sufficient 
margin across the duct wall, i.e. ablate the entire epithelium and ensure loss 
of permeability, which requires a depth of 12 mm; and 4) it must be safe, i.e. 
no steam pops or tissue disruption, which means keeping tissue temperature 
below 8090ºC and avoiding tissue sticking to the electrode. 
Additional technical requirements for a device aimed at endoluminal 
surgery of the pancreatic duct should also include: 1) a suitable diameter to 
fit the duct along the entire route; 2) flexible enough to pass easily through 
the duct, which is not usually straight; and 3) be long enough to cover the 
entire target segment. The electrodes used to create the thermal lesion should 
be on the catheter itself. In this context our objective was thus to develop a 
new catheter-based technique for endoluminal RF sealing of the pancreatic 
duct and to assess its safety and performance on an in vivo porcine model. 
 
4.3. Materials and methods 
The first phase, based on an ex vivo model, was used to tune up the 
experimental setup, which consisted of an RF catheter combined with 
impedance-guided pullback. The aim was to determine the suitability of the 
catheter in terms of diameter, size, flexibility, and ablation protocol. The 
second phase was based on an in vivo porcine model and assessed the safety 
and feasibility of the novel technique with a 30-day follow-up. In both phases 
the electrodes were powered by a Radionics Cosman Coagulator CC-1 
(Radionics, Burlington, MA, USA), a versatile generator previously used with 
endovascular RF catheters for arterial occlusion in liver cancer [8]. 
Impedance evolution was recorded during the ablations by a USB data 
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4.3.1. Tissue samples for ex vivo and in vivo models 
The in vivo study was conducted on 8 Landrace-Large White pigs (27.3 kg 
mean weight), according to the protocol approved by Ethical Commission of 
the Universitat Autònoma de Barcelona (Authorization Number CEEAH 
3487 and DMAH 9583) and the Government of Catalonia’s Animal Care 
Committee. The ex vivo study was conducted on two types of sample: bovine 
liver acquired from a local slaughterhouse, and porcine pancreas obtained 
from 3 pigs, which underwent necropsy under the same authorized protocol 
as that used in the in vivo study. 
 
4.3.2. Considerations on the catheter design 
In general, successful endoluminal ablation should ensure: 1) catheter 
flexibility to operate inside the duct, 2) shallow thermal lesions circumscribed 
exclusively to the tissue around the pancreatic duct (sufficient to completely 
seal the secondary ducts draining into the main duct), and 3) the ability to 
estimate a suitable level of applied voltage from the initial impedance 
measurement. Potential catheter designs for endoluminal ablation should 
also take the following issues into account: number of electrodes (single or 
multiple), function mode (mono-, bi-, multi-polar), electrode type (dry or wet), 
and application procedure (point-to-point or continuous pullback).  
The first tentative test was on a single long RF electrode based on a 3 Fr 
metallic guide whose length was tailored to the lesion length in order to create 
one long lesion by ‘segmental’ ablation. This first idea was discarded since the 
edge effect prevented the formation of a long uniform thermal lesion around 
one RF electrode. Regardless of the ablation time (1020 s), the lesion 
surrounding the electrode was nonhomogeneous and much deeper at the 
edges, which was associated with overheating, audible steam pops (registered 
at 24 s) and tissue sticking. Also, the long metal wire was not sufficiently 
flexible to operate inside soft delicate tissue. 




Figure 19. (a) Overview of the catheter-based technique for endoluminal radiofrequency 
sealing of pancreatic duct. The catheter is introduced into the pancreatic duct through the 
papilla. (b) Detail of catheter tip in which RF power is applied between two electrodes. The 
thermal lesion causes the duct to seal (the illustration is that of a human pancreas). (c) 5 Fr 
bipolar RF catheter used for ex vivo ablations on bovine liver (the most proximal electrodes 
were used for ablations). (d) 3 Fr bipolar RF catheter used for ex vivo and in vivo ablations 
on porcine pancreas.  
 
Another consideration was that a single long RF electrode must be operated 
in monopolar mode, making it difficult to predict the thermal lesion geometry, 
since the exact power delivered to the target site depends on the 
unpredictable electrical characteristics of all the tissues involved in the 
electrical circuit.  
The bipolar mode employs at least two closely spaced electrodes to create 
shallow thermal lesions confined to the inter-electrode space. The applied 
power depends almost exclusively on the characteristics of the tissue between 
the electrodes. Less power is required in bipolar mode to ablate the same 
lesion volume, which is appropriate in terms of safety, especially when 
working on small or fragile organs, such as the pancreas, which is surrounded 
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by other delicate organs. 
A final issue to be considered is the possible internal cooling of the 
electrodes. Although cooled electrodes have an advantage over dry electrodes 
and avoid tissue sticking (e.g. CelonProSurge Applicator, Olympus, 
Germany), they are also known to create deeper thermal lesions than the dry 
type. As the goal in endoluminal ablation is to create relatively shallow 
thermal lesions around the pancreatic duct (12 mm depth) and avoid damage 
to the pancreatic parenchyma or adjacent organs, dry electrodes seem to be 
the better choice. 
For all the procedures we employed commercially available flexible 
catheters, which include a pair of metal electrodes separated by plastic 
insulation. The catheter would be introduced into the pancreatic duct through 
the papilla and would create thermal lesions around the electrodes, as 
illustrated in Figure 19. The lesions could be created either point-to-point (i.e. 
positioning the catheter at one point and then repositioning it to a contiguous 
point after having created a lesion) or continuously by the pullback technique. 
 
4.3.3. Protocol for ex vivo experiments 
Three sets of ex vivo ablations were conducted, two on bovine liver and one on 
pancreatic tissue. Bovine liver was selected for its accessibility, homogeneity, 
and the ease of identifying the shape of the thermal lesions. 
The first set of ex vivo ablations on liver was performed without pullback 
in order to tentatively establishing the relationship between the applied 
power, duration and created thermal lesion. This also allowed us to determine 
the approximate potential starting point for pullback, i.e. when the catheter 
pullback should start to avoid overheating and roll-off (abrupt rise in 
impedance). The applied voltage was 50 V and the ablation durations varied 
according to the roll-off time. 
The second set of liver ablations was conducted with catheter pullback and 
provided information on the relation between pullback speed and lesion 
continuity. Both the first and second sets were conducted with the catheter 
between two fragments of liver (sandwich structure). The pullback sequence 
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was guided by the impedance progress as follows: catheter pullback only 
started when impedance reached a plateau (ensuring sufficient heating of the 
tissue in contact with the electrodes) and with early signs of an imminent 
cutout, i.e. when the impedance attempted to rise (implying overheating). In 
other words, the goal was to keep the impedance as steady as possible, since 
it is reasonable to assume that this implies that the same amount of power is 
being applied along the entire duct, hence ensuring the continuity of the 
thermal lesion without the need for overlapping. Pullback was carried out 
manually by the operator, who moved the catheter according to impedance 
progress as reflected in an audible signal provided by the RF generator. In 
this second set of ex vivo ablations the applied voltage was slightly lower (43 
V instead of 50 V), since preliminary trials had shown that better pullback 
control could be obtained at this value. The liver ablations were conducted 
with a 5 Fr catheter as used in cardiac electrophysiology (see Fig. 19c). Their 
durations varied with the length of the liver fragment. 
Once the impedance-guided procedure was seen to be feasible, a third set 
of ablations was conducted on porcine pancreas. Sample size in this set was 
small (n=3) due to a limited supply of ex vivo pancreatic specimens. Since it 
was not possible to introduce a 5 Fr catheter into the porcine duct, this set 
was finally conducted by a 3 Fr catheter (Minitrode, Bioampere Research, 
Conselve, Italy) with two 3 and 4 mm long 10 mm interspaced electrodes 
(Figure 19d). In this case the applied voltage was also 43 V, which implied a 
power of 5 W.  
 
4.3.4. Protocol for in vivo experiments 
The ablation protocol established in the ex vivo trials was then tested on 8 
Landrace-Large White pigs. This sample size was used in a previous study 
with a similar objective [7]. Prior to surgery, all the animals underwent a 12 
hour-fast. All were premedicated with azaperone (4 mg/kg intramuscularly 
(IM)) (Stresnil ®, Ecuphar veterinaria, Spain), ketamine (10 mg/kg IM) 
(Ketamidor ®, Richter Pharma, Austria) and morphine (0.2 mg/kg IM) 
(Morfina B.Braun®, B.Braun Medical, Spain). Induction was performed with 
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propofol 2–4 mg kg-1 intravenously (IV) (Propofol lipuro®, B.Braun Vetcare, 
Spain. After induction, all the animals were intubated with an orotracheal 
tube, and anaesthesia was continued during the surgical procedure with 
isoflurane 2% (Isovet®, Piramal Critical Care Limited, UK) in 100% oxygen 
through a rebreathing circuit. Lactated Ringer’s solution was infused at a rate 
of 10 mL/kg/h during the peri-operative period. Antibiotic therapy was 
administered with cephazoline 20 mg/kg IV (cefazolina normon®, 
Laboratorios Normon, Spain) via the cephalic vein.  Heart rate, respiratory 
rate, pulse oximetry, electrocardiography, non-invasive blood pressure and 
capnography were monitored during anaesthesia using a multi-parameter 
monitor (VetCare®; B Braun Vetcare, Spain). 
Thermal ablations were performed with the same 3 Fr catheter as used on 
the ex vivo pancreas introduced into the duct through the pancreatic papilla 
by means of laparotomy and enterotomy. Once the catheter was placed in the 
end duct (10 cm insertion depth), RF power (37 V) was applied. As in the ex 
vivo experiments, the catheter was pulled back along the entire duct until one 
of the electrodes was no longer inside it (RF generator automatically shut 
down). To control the pullback speed, the operator continuously monitored 
impedance visually on a laptop and by following the audible signal emitted 
by the RF generator.  
After this process, enterotomy and laparotomy were closed in the 
conventional manner. The animals were kept alive for a 30-day follow-up, 
after which all were again anesthetized, intubated and ventilated for 
laparotomy and dissection of the entire pancreas, which was then 
immediately placed in 10% buffered neutral formalin. The animals were then 
euthanized using a commercial euthanasia solution. The principal duct of the 
dissected pancreas was identified and cannulated and the following tests 
were conducted: a feasibility test, consisting of reintroducing the catheter into 
the pancreatic duct through the duodenal papilla, and a permeability loss test 
consisting of injecting saline into the ablated duct. The pancreas was divided 
into 3 mmthick sections for further histological analysis and 2 or 3 5 µm 
samples from each section were stained with hematoxylin and eosin and then 
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evaluated by light microscopy. Pathologists unaware of the experimental 
design assigned the degree of exocrine pancreas atrophy from 0 to 5. 
All the surgical procedures were performed by the same surgical team (AA 
and XM1). To analyze sealing effectiveness, alterations of the animals’ weight 
increments at 30 days after surgery, feasibility of reintroducing the catheter 
into the pancreatic duct, and duct permeability were considered. The degree 
of atrophy was determined by histological analysis.  
 
4.4. Results 
4.4.1. Ex vivo experiments  
In the first set of ex vivo ablations on bovine liver (without pullback) initial 
impedance was 606 ± 14 Ω, and the mean applied power was 5 W (50 V 
applied voltage). In all the ablations we observed a similar impedance 
pattern, which went through the following consecutive phases: 1) gradual 
initial impedance drop toward a steady minimum value, 2) plateau phase 
with a fairly steady minimum value, and 3) abrupt impedance rise. The 
beginning of the plateau phase occurred at 12±3 s and coincided with the start 
of visible and audible signs of tissue overheating, such as steam pops, and 
also with a visible thermal lesion (tissue whitening). Impedance during the 
plateau was 384±20 Ω. The abrupt impedance rise occurred at 21±6 s and was 
preceded by audible pops 5 s before ablation ended. 
The second set of ex vivo ablations employed the pullback technique and an 
attempt to keep a constant impedance value as long as possible, which meant 
keeping the plateau for as long as possible. The applied voltage was reduced 
to 43 V, since 50 V led to rapid tissue overheating, electrode sticking and a 
non-uniform lesion. As in the first set, the initial impedance and plateau 
impedance were 568±48 Ω and 334±37 Ω, respectively. In this case, due to the 
voltage reduction, applied power was 5 W. In this second set we identified 
two main factors associated with pullback that affected lesion geometry and 
size: speed (slow vs. fast) and continuity (intermittent vs. uninterrupted –
                                                          
1 (AA) PhD Anna Andaluz, (XM) PhD Xavier Moll, Departament de Medicina i Cirurgia Animals, Facultat de Veterinària, 
Universitat Autònoma de Barcelona, Barcelona, Spain. 
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continuous–). A fast and continuous pullback caused an initial minor 
impedance drop and led to greater number of abrupt impedance rises, 
although without visible lesions. When pullback was slow, two different types 
of behavior were seen that depended on pullback continuity:  
1) When pullback was slow and intermittent, impedance followed a 
sawtooth waveform with small abrupt rises (see black arrow in Fig 20a) 
each time the catheter was moved, so that the evolution matched well 
with the lesion pattern. The intermittency involved tissue charring and 
sticking just before the end of pullback, or at extremely low speed, while 
gaps appeared (absence of thermal lesion) with a fast pullback. 
 
 
Figure 20. Results of the second set of ex vivo experiments. (a)-(c) Examples of impedance 
evolution. (a) Small-amplitude sawtooth associated with slow and intermittent catheter 
pullback. (b) and (c) Smooth patterns associated with slow and continuous catheter pullback. 
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2) When pullback was slow and continuous, the impedance waveform 
smoothed out (see Fig. 20b) and avoided tissue sticking. The lesions 
thus produced were also uniform in depth, with a whitish zone 
extending continuously 1 mm around the electrode along the entire 
ablation line (see Fig. 20d). In these cases the plateau was reached in 
23 s, after which pullback was applied at a mean speed of 0.07 cm/s. 
When the speed became too slow, impedance gradually rose (black 
arrow in Fig. 20c), which was interpreted as an early sign of an 
imminent impedance jump (implying overheating) and therefore 
pullback was speeded up. 
 
The third set of ex vivo ablations was conducted on pancreatic tissue with a 3 
Fr instead of a 5 Fr catheter, since the pancreatic lumen was narrower than 
expected. The initial impedance was 523±29 Ω, a value slightly lower than 
that obtained by a 5 Fr catheter on bovine liver. The applied voltage was kept 
at the same level as in the previous set (43 V). Impedance followed the three-
phase pattern observed in the first two sets of ex vivo ablations. The time to 
reach plateau was more than 100 s, which was three times longer than in the 
two previous sets. The impedance value at the plateau was 302±40 Ω (see Fig. 
21a). Abrupt impedance increases were associated with tissue sticking and 
carbonization points (see black arrow in Fig. 21b), just after which the 
catheter was relocated. Unfortunately, this movement caused visible gaps 
(see white arrow in Fig. 21b), since they were associated exactly with the 
zones where the electrodes did not apply power as the catheter was moved. 
As in the previous sets, we also observed that pulling back too fast impeded 
the creation of visible thermal lesions. Overall, the lesions created in this 
third set showed larger margins (23 mm) than the two previous sets on liver 
with a 5 Fr catheter. During the ablations, more abrupt impedance changes 
and more roll-offs occurred, which contributed to a more intermittent 
pullback and to irregular lesions in terms of depth and continuity (i.e. with 
gaps). 




Figure 21. Results of the third set of ex vivo experiments. (a) Typical impedance during 
ablation. (b) Lesion created along the pancreatic duct in a pancreas treated with 43 V and 
pullback as continuous as possible. Gray bands show power cut off instants after abrupt 
impedance increases associated with tissue sticking and carbonization (black arrow in (b)). 
After this event pullback was always speeded up in order to relocate the catheter, which in 
turn led to some visible gaps (white arrow in (b)).  
 
4.4.2. In vivo experiments 
Since the tissue lesions of the in vivo group could not be seen until 30 days 
after the procedure, the evolution of the electrical variables was the only 
indicator for creating uniform and continuous thermal lesions. The mean 
initial impedance was 308±60 Ω, considerably lower than in the ex vivo 
specimens. The applied voltage was reduced to 37 V, which implied a power 
of 5 W (comparable to the value measured in ex vivo ablations). A time of 
30 s was required to reach the impedance plateau (220±35 Ω), at which time 
pullback started. Impedance followed the same three-phase pattern as in the 
ex vivo ablations. However, the in vivo ablations showed a higher incidence of 
roll-offs, estimated as one every 40 s of ablation, and the impedance rises 
usually involved tissue sticking, which forced us to relocate the catheter 
rapidly in order to complete the ablation, which often required vigorous 
action. This meant the impedance evolution was more irregular than in the 
ex vivo experiments. Total ablation duration varied slightly in the trials in 
relation to specific duct length and roll-off occurrence. An average of 11 cm of 
pancreatic duct was ablated at a mean pullback speed of 0.1 cm/s.  




Figure 22. Results of the in vivo experiments. Macroscopic images of one of the treated 
pancreas and cross sections at the level of the head (a) and body (b). Red dotted circles 
indicate the position of the main duct. Lumen was not completely closed in all cases and 
ductal dilation was observed, particularly in the body (units in cm). Grey dashed line 
indicates the main duct position in pancreas. 
 
During the 30-day follow-up the animals experienced alterations of stool 
consistency. After this period, their mean weight was 31 kg, which meant a 
slower than normal rate of weight gain (4 kg per 30 days). At necropsy, the 
feasibility test to verify the presence of ductal occlusion failed, since it was 
impossible to re-insert more than a few centimeters of the catheter into the 
duct, due to the lumen being too narrow. This also meant we could not 
perform the permeability test, as the liquid could not be injected as planned 
through the distal end of the duct. All this suggested that sealing was 
completely effective after 30 days at the level of the duodenal papilla. Beyond 
the papilla, a macroscopic view of cross-sections of pancreatic duct revealed 
different degrees of ductal dilation (diameter ranging widely from <1 mm to 
>10 mm), although at the level of the head the lumen seemed completely 
sealed in all cases (Section A in Fig. 22).  
 




Figure 23. Results of in vivo experiment. Histological images of normal pancreas (a)-(c) and 
samples with sealing-induced pancreatic atrophy (d)-(f). Compared to normal pancreatic 
tissue, the treated samples show evident atrophy of the acinar component (purple dye) with 
only intralobular ducts remaining (d,e); the epithelium of the interlobular ducts is flattened 
or has been lost ((f), black arrow); marked interlobular fibrosis (d)-(f); scattered inflammatory 
infiltrate (e,f). H&E ×5 (a,d) and ×20 (b,c,e,f). 
 
Figure 23 shows histological images of normal pancreatic tissue and 
pancreas after treatment. The histological study of the treated samples 
revealed complete acinar atrophy and that only the intralobular ducts 
remained after ductal ablation (Fig. 23d and 23e). The epithelium of the 
interlobular and some of the intralobular ducts showed a metaplasia from 
columnar or cuboidal to squamous and was lost in other areas (Fig. 23f). All 
the samples showed marked periductal and interlobular fibrosis (Fig. 23d-
23f) and scattered inflammatory infiltrate (Fig. 23f). 
 
4.5. Discussion 
Sealing the pancreatic duct has always been challenging due to the risk of 
pancreatic juice leaking into the peritoneal cavity, which continues to be the 
main complication contributing to the high mortality rate [7]. The 
endoluminal RFA with pullback proposed here could potentially reduce this 
risk. Moreover, being a minimally invasive technique, it offers the advantages 
of a likely faster recovery and fewer side effects than injecting a sealing agent 
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or tissue suturing. To our knowledge, this is the first study to examine the 
feasibility of the catheter-based RF sealing technique for the pancreatic duct. 
As this was a development study, it had several phases to progressively fine-
tune the proposed technique (catheter and ablation protocol) and finally 
obtain relevant information on its safety and performance on an in vivo 
porcine model. 
 
4.5.1. Initial steps fine-tuning technique 
The first phases conducted on liver ex vivo fragments showed how the 
different variables involved interact with each other during ablation with 
pullback. What we learned was that: 1) a few watts (5 W) are enough to 
create 12 mm deep lesions; 2) pullback must begin when the impedance 
plateau is reached, which may coincide with audible pops; 3) it is possible to 
modulate the rate of pullback to keep the impedance as steady as possible, 
i.e. to try to maintain the plateau phase during the entire procedure; 4) this 
can be done by monitoring impedance and/or by an audible signal associated 
with impedance progress; and 5) if all these conditions are observed, the 
thermal lesion can be continuous (without gaps) along the entire path. 
When we tried to transfer these conditions to the case of the pancreatic 
duct (pancreas ex vivo ablations), we learned that: 1) a narrower catheter 
diameter is required (3 Fr instead of 5 Fr); 2) catheter pullback through the 
pancreatic duct is less straightforward than the simple movement between 
two slices of liver tissue; 3) this means that the impedance-guided lesion is 
not so effective in the pancreas, with sticking, a need for overlap, and possible 
gaps; 4) sudden impedance rises are possibly related to tissue sticking and 
require moving the catheter, with the possibility of gaps; 5) gaps can be also 
produced by excessive pullback speed; and 6) when present, thermal lesions 
are 23 mm deep. This information was used to carry out a 30-day survival 
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4.5.2. Clinical assessment of the technique 
On planning the in vivo study we expected thermal ablation inside the 
pancreatic main duct to produce the following phenomena: 1) occlusion of the 
small exocrine ducts branching from the main duct and subsequent acinar 
atrophy, causing the suppression of exocrine secretions; and 2) shrinkage of 
the collagen fibers around the main duct and subsequent reduction of its 
lumen, making it less permeable. Initially we thought that in order for these 
phenomena to occur efficiently, a continuous thermal lesion had to be created 
along a segment of the main duct. This was probably over-optimistic, since 
although thermal ablation produces immediate tissue shrinkage (due to 
protein denaturation and collagen contraction) this could only create a partial 
occlusion, as opposed to other mechanical methods (such as suture or stapler). 
What the in vivo study revealed is that it is very difficult to create 
continuous lesions along the pancreatic duct, possibly due to the irregular 
anatomy of the main duct, but also due to the technical limitations of the 
impedance-guided protocol. In fact, gaps were observed in the ex vivo 
pancreas just after ablation. In the same way, the sudden impedance rises 
during in vivo ablations suggest the possible presence of gaps in the lesion 
and the possibility of the diameter not being reduced along the whole ablation 
length. This was later confirmed in the macroscopic analysis, where the main 
duct was not completely occluded in all zones. Complete duct occlusion at the 
pancreas head was also evident from the impossibility of reinserting the 
catheter through the duodenal papilla. We still do not have a convincing 
explanation of why the proximal duct (head zone) was more occluded than the 
distal duct. The images in Fig. 22 also show that the ablated duct was usually 
circular in shape, regardless of the dilation diameter or location, which 
suggests that the energy deposition occurred symmetrically around the 
electrodes and was limited in depth. 
Interestingly, despite the existence of lesion gaps and presence of non-
occluded segments, clinical observations during follow-up and histological 
findings were compatible with complete exocrine atrophy. The atrophic 
pancreas was deprived of acini to secrete digestive enzymes, which caused the 
  127 
 
 
failure of the digestive functions. All the animals experienced digestive 
alterations and a notably reduced rate of weight gain after the 30-day follow-
up.  
In view of all the results, the complete occlusion of the entire main duct 
may not be required to generate complete exocrine atrophy. In fact, it is 
possible that the partially occluded duct segments also contributed to the 
exocrine atrophy. Since RF ablation also severs duct walls and produces 
thermal necrosis and apoptosis of the ablated zone, it is likely that atrophy 
and acinar cell loss are also a result of thermally-induced apoptosis. It is thus 
reasonable to assume that a fully continuous lesion along the main duct might 
not be necessary to achieve exocrine atrophy, which would be triggered not 
only by an immediate RF-induced effect, but also by biological processes 
within 30 days after ablation. 
 
4.5.3. Safety issues 
Regarding the safety issues involved in the ablative technique, we must keep 
in mind that bipolar RFA has already been clinically used for endoluminal 
ablation of vessels and biliary duct, so the concept of endoluminal ablation 
itself is well-known and assumed to be safe. The risks of using RFA instead 
of another mechanical method, such as staplers, sutures or clips, could 
include overheating of the target tissue and unintentional ablation of the 
neighboring tissue (e.g. intestine). In our study these risks were minimized 
by establishing a ‘safe ablation environment’ by trying to keep the pancreas 
as far as possible from other viscera during ablation by simple mechanical 
deviation. In addition, all the procedures were accomplished by personnel 
experienced in using RF-based devices. Finally, the absence of postoperative 
complications associated with RF power suggests that the proposed ablation 
method keeps risks at a reasonably low level. 
 
4.5.4. Technical feasibility 
The ablation control proposed in this study is entirely based on impedance 
progress. We discarded temperature monitoring due to it being technically 
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complex to include temperature sensors in such a small catheter. Moreover, 
while a temperature sensor would only provide information on the 
temperature in the tissue in contact with it (not necessarily the maximum 
tissue temperature), impedance gives a more complete picture of the 
characteristics of tissue affected by ablation through the direct relationship 
between electrical conductivity and temperature. In fact, this technique has 
been used previously in the management of biliary tumors and venous 
obstruction or other venous insufficiencies [1013]. While we designed our 
own endoluminal RFA protocol, other studies used commercial devices 
designed for treating varicose veins (e.g. Celon ProCurve, Olympus, 
Germany). In both cases the method is based on impedance feedback for 
catheter guidance by visualizing impedance and power evolution and 
attending to audible signals. It also allows working in a specific impedance 
range that cuts out when exceeded. We had to adapt this technique to the 
present study, since endoluminal RFA had never been used before to seal the 
pancreatic duct. The delicate pancreatic tissue structure required a flexible 
applicator and the right catheter to fit a 1 mm duct diameter, which ruled 
out the use of the commercial product of 5 Fr. 
In addition, impedance monitoring has already been proposed to estimate 
the temperature and lesion size during RF ablation due to the inverse 
relationship of both parameters [14]. Tissue heating enhances ion mobility 
and current flow and thus produces a characteristic impedance drop in the 
early stages of ablation. Although thermal lesions in high-temperature 
ablative techniques require temperatures in the range 50100ºC, it is also 
known that lesion evolution is closely connected to the temperature-time 
relationship, which depends on the amount of power applied. In particular, it 
is known that a few minutes of exposure at 50ºC triggers progressive tissue 
shrinkage and irreversible tissue damage [15], while only a few seconds at 
60ºC produce tissue coagulative necrosis seen as a whitish area in the ablation 
zone [16,17]. Once thermal equilibrium has been reached, the impedance 
value stabilizes at the minimum and lesion size remains static. Further 
ablation leads to tissue overheating and vaporization at temperatures 
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between 100 and 105ºC and is characterized by audible steam pops, an abrupt 
impedance rise, tissue carbonization and sticking [17]. Once focused on 
impedance monitoring, our findings identified three different phases in its 
progress during ablation: 1) a drop associated with initial heating, 2) a 
plateau phase, and 3) occasional abrupt increases associated with 
overheating. All the phases could easily be distinguished in our ex vivo 
findings, in which whitish and carbonization zones appeared, suggesting that 
the tissue was in fact exposed to the 60100ºC range. Overheating incidents 
also occurred in the in vivo study and suggest that the tissue was exposed to 
temperatures of up to 100ºC. The longer the plateau phase, the longer the 
ablation with sufficient power delivery and without carbonization. It has also 
been suggested that keeping the plateau impedance at a target value for a 
specific time should lead to the desired lesion depth [9]. The value of the 
plateau phase depends on tissue type and other conditions that affect its 
electrical properties, such as hydration or blood irrigation [18,19]. For 
instance, in our study the differences between the ex vivo and in vivo models 
were possibly related to additional heat loss by convective blood perfusion 
cooling (also known as heat sink effect), which is only present under in vivo 
conditions. Other factors could also have affected these differences, such as a 
smaller impedance drop and a higher threshold temperature for coagulative 
necrosis, finally producing smaller lesion depths in the in vivo case. 
Accordingly, we observed that in vivo samples had nearly half as low initial 
impedance values (308±60 Ω vs 523±29 Ω) and a smaller impedance drop 
(220±35 Ω vs 302±40 Ω at plateau) than ex vivo specimens. We were not able 
to assess the differences in lesion depth between ex vivo and in vivo cases 
since in the latter case the lesion dimensions were assessed after a 30-day 
follow-up period. However, our findings can be discussed in the light of 
previous liver studies (with a similar pancreas blood perfusion rate, 860±170 
mL/min/kg vs. 767±357 mL/min/kg [20]). These studies showed that in vivo 
lesions have a 3644% smaller diameter than ex vivo lesions [21-23], which 
suggests that the in vivo pancreatic lesions created in our study could be 
around 1 mm deep (since lesion depth was 23 mm in the ex vivo case and 
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similar power levels were used in both cases). 
Additionally, different studies have reported that tissue shrinkage (which 
starts at 50ºC) produces up to 2030% of tissue constriction of the initial 
margin and therefore the real ablation zone is actually greater than that 
measured [15,24,25], while a limited degree of tissue shrinkage could also 
reduce the chances of complete mechanical occlusion of the duct, although, as 
seen in our study, it was sufficient to reduce the duct diameter to less than 
the catheter diameter and ruled out catheter reintroduction. 
Due to variations in the electrical properties of ex and in vivo tissue, a 
lower voltage value was used in the in vivo study (43 V vs. 38 V). This change 
also affected the pullback speed (~0.03 cm/s vs. 0.1 cm/s), but in all cases a 
power of ~5 W could be delivered, suggesting that the delivered power, as 
determined by applied voltage and pullback speed, is the vital parameter in 
achieving successful RFA. The power and pullback speed values used in our 
study were noticeably lower than those usually reported for venous ablation 
(18-25 W and 0.5-1 cm/s, respectively) [9,12,13,26,27]. Numerous studies have 
reported that the recommended clinical power and pullback speed values can 
increase the incidence of tissue carbonization and sticking [12]. An additional 
issue in obtaining permanent sealing is the need to reapply the treatment 
(overlapping) to provide sufficient energy for effective sealing [28]. 
Interestingly, Badham et al. [12] suggested that values of 6 W and 0.08 cm/s 
are the most optimal to obtain a successful vein lesion by single RF ablation 
and avoid tissue overheating and sticking. These values are very similar to 
these employed by us (5 W, 0.03-0.1 cm/s). It is important to note that while 
we aimed for a slow continuous pullback, Badham et al. used a discontinuous 
pullback, so that 0.08 cm/s was really an approximate value. This similarity 
could be owing to the electrical properties of both tissues. In the in vivo study 
we found that a large number of abrupt impedance increases and tissue 
sticking events were inevitable. This problem could pose a serious risk of soft 
tissue rupture during the treatment. The relationship between the applied 
power and pullback speed determines the required energy level and the rate 
at which it is delivered to the tissue, and thus the final thermal dose to cause 
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tissue damage. The optimization of these parameters is still pending. 
The outcomes obtained from this technique are undoubtedly affected by the 
additional factor of the operator’s skill in controlling catheter pullback [26]. 
As already mentioned, an excessively slow pullback implies greater power 
deposited in the target area together with carbonization and sticking, while 
an exceedingly fast pullback produces gaps or even no lesion at all. Although 
the manufacturers usually recommend the appropriate powers and speeds to 
obtain continuous lesions and avoid overheating, the inherent tissue 
heterogeneity impedes creating a uniform lesion along the entire path. The 
operator’s skill thus plays a vital role in varying pullback speed according to 
the impedance variations encountered. The amount of delivered power and 
pullback speed will also vary according to the desired outcome and may differ 
from the manufacturer’s recommendations [27,28]. For all these reasons it is 
important to first estimate the relationship between impedance, delivered 
power and the required thermal lesion before applying endoluminal RFA with 
pullback.  
 
4.5.5. Limitations of the study 
Although our final clinical objective is the management of the pancreatic 
stump, the in vivo study was conducted on a non-transected pancreatic duct. 
A transected pancreas model would be more complex and would entail a 
higher risk of pancreatic leakage. Further research on this matter should 
therefore be conducted involving endoluminal RF sealing of the transected 
pancreatic duct in order to confirm the feasibility of the technique on a more 
realistic model. 
As regards the clinical implications, it is important to note that the porcine 
model used in this study is anatomically different to the human pancreas in 
certain respects, as it has a secondary duct branching out from the main 
pancreatic duct (see Fig. 1 from [7]). In our study this duct was not ablated 
and therefore maintained its enzymatic secretory function, which could have 
reduced the effectiveness of the proposed technique. For this very reason the 
technique could be even more effective in the human pancreas. 




The impedance-guided endoluminal RFA technique designed to seal the 
pancreatic duct seems to be a promising, feasible and safe alternative for 
management of the pancreatic stump and reducing the risk of leakage. 
Although power and pullback speed still need to be optimized, the findings 
obtained suggest that a fully continuous RFA lesion along the entire duct may 
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The main goal of the PhD Thesis was to develop computer models and 
experimental studies to examine deeply the phenomena related with RF 
ablation as minimally invasive therapy. In particular, three separate studies 
have been conducted: pulsed RF for pain relief, RF ablation of hepatic tumor 
using a new cooled wet electrode, and endoluminal sealing of pancreatic duct 
by bipolar RF ablation. 
 Regarding the use of RF ablation for pain treatment, there has been an 
unceasing interest for understanding the mechanisms behind the positive 
results of pulsed RF. This is due to the lack of the ultimate explanation and 
empirical evidence that would support possible hypotheses that have been 
posed so far. In line with this statement, Chapter 2 describes a computer 
study on PRF performance to evaluate the electrical and thermal effects of 
different pulse protocols and PRF implications in a possible nerve 
electroporation. The concepts discussed in our study covered two main 
assumptions of PRF technique, such as to avoid tissue thermal damage and 
to provide a sufficient “electrical dose” for an effective pain release. In terms 
of electric field dosage, it is known that higher dose increases the electrical 
effect. However, the number of currently used protocols suggests that these 
have not yet been standardized. Though, some protocols might be chosen 
preferentially over others. The results from a number of studies have also 
showed that the effectiveness of PRF varied in different pain location. Thus, 
optimization and standardization of location-specific PRF treatments should 
be the objective of future research studies.  
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 The study in Chapter 3 focused on examining tissue hydration technique 
for RF ablation by a novel ICW electrode with two expandable perfusion 
needles. The main contributions involved building a computer model with 
realistic spatial distribution of the infused saline, which was based on an in 
vivo study on pig model. Also, mathematical description of saline-infused and 
non-infused zones of tumor tissue was provided and the modeled results were 
compared with those of the clinical trial. Increased tissue hydration has been 
proven to improve ablation lesion size by many studies, which employed 
different approaches for tissue irrigation. One of them was a design used in 
this study of ICW electrode with expandable perfusion needles, which 
ensured distant from the electrode saline infusion. Nevertheless, the common 
issue regarding saline injection is associated with the risk of uncontrolled 
thermal damage. This is due to the unpredictability of the perfusate 
distribution in tissue, and the fact that the resulting distribution would define 
the ultimate ablation zone. The study has raised the respective issues by 
proposing an experimental-based geometry for realistic saline spatial 
distribution. This approach has also shown how the proximity to blood 
vessels, acting as preferential drainage paths, importantly affected the final 
result. The findings also suggested that the establishment of clinically 
oriented computer models is highly recommended to improve prediction and 
optimization of RFA treatments with ICW electrodes. Additionally, a 
comparative computer modeling study could be conducted, in which RFA with 
ICW electrode and microwave ablation would be analyzed based on a 
currently running clinical trial. 
 Finally, a new endoluminal sealing technique for management of the 
pancreatic stump has been proposed in Chapter 4. This study can be 
considered as the first step forward in offering a promising alternative to 
patients with a high risk of morbidity after being submitted to the currently 
available treatments. The study describes a process of protocol fine-tuning for 
the impedance-guided RF ablation with pullback. To employ the ex vivo and 
in vivo models has shown to efficiently ensure the safety of the ablative 
technique. Despite the encouraging preliminary results and the method 
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considered as feasible, the proposed experimental model was relatively 
simple, regarding to what the real clinical case would look like. Therefore, a 
further experimental study is currently being conducted on more complex 
scenarios with surgically resected pancreas. This ongoing work addresses the 
pancreatic leakage issue, which is one of the most important complications 
nowadays that carries a substantial risk of fatal outcome.  
 Different methodologies have been used to accomplish this PhD Thesis. 
Regarding phantom and ex vivo models, although more simple than in vivo 
studies or clinical trials, their use can provide a valuable insight when 
adapted to specific study requirements. The chosen model should be as simple 
and efficient as possible but not simplistic, which also means that in some 
cases ex vivo model might be preferable over studies on living research 
subjects. The example of it could be the fine-tuning study in Chapter 4. 
However as shown in Chapters 3 and 4, some studies necessarily require a 
complex living system that would feature physiological phenomena affecting 
treatment effectiveness. Furthermore, computer models make a large 
contribution to the optimizing of performance, time and cost of the 
therapeutic techniques. Consequently, also in the scope of this work computer 
models have been proved to be complementary and essential to provide an 










The studies developed in the context of this PhD Thesis have provided more 
insight into the electrical and thermal performance of RF-based minimally 
invasive therapies applied to pain management and surgical oncology. In 
particular, the findings indicated possible risks and proposals of 
enhancement for the analyzed therapies. New techniques for a more effective 
treatment of tumors have also been suggested, and showed favorable results. 
The following conclusions address the separate studies listed in the Preface 
chapter. 
Different PRF protocols analyzed by computer modeling in the Chapter 2 
aimed at improving their electrical performance and ensuring safe tissue 
temperature. The study has proven that higher voltage and pulse frequency 
repetition but shorter pulse duration increased the electrical effect of PRF 
and reduced slightly the thermal impact on tissue. The study has suggested 
that the risk of thermal damage could be avoided when the temperature 
controller was used. Consequently, this computer modeling study has also 
considered that PRF might provide a sufficient electric field magnitude to 
cause electroporation. Finally, agar phantom experimental study was found 
suitable to validate computer model accuracy. These findings could be used 
to establish new and more efficient PRF protocols.   
The study in the Chapter 3 examined various saline spatial distributions 
in order to develop an enhanced tumor model for RFA with new ICW 
electrode, and based on a realistic trial-based geometry for the infused tissue. 
The findings showed that a realistic saline spatial distribution differed 
noticeably from ideal spherical geometry, which is typically proposed in 
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computer modeling studies. The effect of different saline spatial distribution 
was also observed on the duration of simulated ablation. However, the main 
impact on computer model accuracy has been the complexity of saline-infused 
tumor model, in which infused and non-infused zones of tumor were defined. 
Therefore, the study indicates importance of building clinically-oriented 
computer models in achieving better approach of numerical studies. 
A new catheter-based technique for endoluminal sealing has been proposed 
in the study in Chapter 4 as an alternative for management of the pancreatic 
stump. The findings showed the feasibility of using impedance as a guidance 
parameter for continuous RFA. On the other hand, they also suggested that 
an effective sealing could be obtained regardless of the lesion continuity along 
the duct. This technique could be a promising and safe method for reducing 
the risk of leakage and patient morbidity during intervention, and thus, it 
lays fundaments for future studies on more realistic and complex 
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